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Abstract 
 Opioid use disorder in pregnancy has escalated perilously in BC in recent years, 
corresponding to the epidemic observed in the general population. Although evidence-informed 
treatments exist, many pregnant women are unable to access life-saving treatment due in part to 
their rural or remote location. Advances in telemedicine (TM), in particular videoconferencing-
based technology innovations, are postulated as one way to improve rural residents’ access to 
primary care services. Presently, little is known about the effectiveness and efficiency of 
providing opioid agonist treatment via distal technologies for pregnant women living in northern 
BC. Therefore, an integrative literature review has been conducted to answer the following 
research question: Can nurse practitioners deliver effective and efficient TM-based care for 
pregnant women with opioid use disorder living in northern BC? 
 Findings of this review suggest there is currently not enough quality evidence to 
determine whether TM can meet the needs of rural pregnant women in BC with opioid use 
disorder and to what extent TM could provide effective and efficient care in a rural context. In 
fact, evidence suggests that health care providers and researchers need to step back from current 
TM approaches and return to the developmental phase of designing, implementing, and 
evaluating health care service delivery via TM. Recommendations and strategies for TM 
implementation at the policy, organizational, and patient levels for primary care providers are 
discussed. 
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Chapter One  
Introduction 
Canada is in the midst of an opioid use epidemic involving both licit and illicit forms of 
the potent narcotics. Canada ranks with the United States as having the highest opioid 
consumption in the world (International Narcotic Control Board, 2015). Opioid use in pregnancy 
is associated with an increased risk of adverse outcomes for both mother and fetus. Research 
suggests that untreated opioid use disorder during pregnancy is associated with a lack of prenatal 
care, increased risk of placental abruption, preterm labor, maternal obstetrical complications,  
neonatal abstinence syndrome (NAS), and fetal death (Schempf & Strobino, 2008; SOGC, 
2017c). Additionally, untreated opioid use disorder is associated with engagement in high-risk 
activities such as sex trade work which exposes women to STIs, blood-borne pathogens, 
violence, and legal consequences (American College of Obstetricians and Gynecologists, 2017). 
The medical and legal consequences associated with opioid use disorder can lead to disruptions 
in social support and may add to stigmatization of pregnant women. Therefore, it is imperative to 
advocate for this vulnerable group, particularly in regards to improving access to treatment. 
Pregnancy provides an important opportunity to identify and treat women with substance use 
disorders (SOGC, 2017c); therefore, all primary care providers need to take an active role in the 
management of opioid use disorder in pregnancy. Strategies to help alleviate the devastating 
outcomes related to this epidemic are keenly sought and include access to treatments based on 
high quality evidence. 
The standard treatment for opioid use in pregnancy is methadone or buprenorphine 
agonist treatment (British Columbia Center on Substance Use [BCCSU], 2017; Jumah, 2016; 
Jumah, Graves, & Kahan, 2015; SOGC, 2017c). Exposure to either of these treatment 
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medications in utero can result in NAS; however, using these treatments among pregnant women 
with opioid use disorder improves outcomes for both mother and fetus compared with those who 
receive no treatment (Jones et al., 2008; Jumah et al., 2015; Winklbaur et al., 2008). Maintenance 
therapy with methadone or buprenorphine provides a steady concentration of opioids in the 
pregnant woman’s blood, preventing the fetus from repeatedly experiencing cycles of opioid 
toxicity and withdrawal, which contribute to the known harms and poor fetal outcomes 
associated with OUD in pregnancy (Finnegan, 2013).  
Despite evidence and guidelines (BCCSU, 2017) supporting methadone and 
buprenorphine treatment for pregnant women with OUD, rural populations experience 
considerable difficulties accessing such services to initiate or maintain therapy. The following 
vignette illustrates the importance of accessible treatment for opioid use disorder in pregnancy 
and was adapted from Finnegan (2013): 
At age 13, Arlene started using heroin. Now, 32 and living in northern BC, she continues 
her habit on a daily basis. Health care services are offered by multiple providers that provide 
care once a month on a fly-in bases in the reserve community where Arlene lives. With a 
population of only 500 people, and situated 600 km from the nearest tertiary center, Arlene does 
not have immediate access to treatment for opioid use disorder. After a series of miscarriages 
and elective abortions, she becomes pregnant. This time she decides to keep the baby because 
she cares about the father, Derek. While Derek also uses substances, he too wants to have the 
baby. Five months into her pregnancy, Arlene considered seeing a doctor but she was afraid her 
baby would be apprehended because she had not stopped using heroin. She also thought about 
quitting or cutting down but did not know who to ask for help. She remembered her cousin 
recently had her baby apprehended at the hospital due to prenatal substance use; therefore, 
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Arlene and Derek decided not to access care. At seven months, Arlene went into labor and was 
transported to a tertiary center where she delivered Annie, a preterm baby weighing just 1,500 
grams (a little over three pounds). Annie had difficulty breathing and very low calcium and 
sugar levels in her blood. Within the first day of life, she had seizures, which the doctors 
attributed to a brain hemorrhage resulting from preterm birth. Because of Arlene’s recurrent 
heroin use, which was inconsistent in both frequency and dose, her fetus had likely experienced 
equally recurrent episodes of abstinence (deprivation of drugs) and overdose. Baby Annie was 
very sick and needed treatment in the neonatal intensive care unit (NICU). While Arlene and 
Derek came occasionally to the nursery to see Annie, they were usually high and disruptive; on 
several occasions they had to be escorted out by security. Both Arlene and Derek were away 
from family and supports during this time. After three months in hospital, Annie recovered. 
Arlene said she loved Annie, however her heroin use continued untreated. As a result, Annie was 
placed in a foster home for medically disabled children. Her prognosis for normal growth and 
development is poor. Subsequently, Arlene and Derek returned to their northern community 
without Annie and without treatment.  
The rationale for opioid agonist treatment during pregnancy is multifold. The medical, 
social, and legal consequences that accompany this vulnerable population are devastating. For 
Arlene, Derek, and Annie lack of treatment led to a lack of prenatal care, preterm delivery, poor 
fetal outcome, and child apprehension. This situation might have turned out differently if the 
standard treatment for opioid use disorder in pregnancy was accessible to Arlene in her rural 
home community.  
In a recent Canadian systematic review, accessibility and availability were identified as 
the most significant barriers to receiving treatment among rural pregnant women with opioid use 
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disorder (Jumah, 2016). The Canada Health Act promotes accessible care for all citizens 
regardless of gender, race, or place of residence, through the publicly funded Canadian health 
care system. This includes considering the specific needs of vulnerable populations in northern 
BC such as pregnant women with OUD (BC Charter, 2007).   
Telemedicine (TM) applications represent one strategy for potentially addressing many of 
the key challenges to providing treatment for rural pregnant women in northern BC. In obstetrics, 
TM has been used to report ultrasounds, counsel patients, and provide prenatal consultations 
(Abrans & Geier, 2006; Rashiah et al., 2006; Vinals, Mandujano, Vargas, & Giuliano, 2005); 
interpret non-stress tests (Hod & Kerner, 2003; Kerner et al., 2004); and manage gestational 
diabetes (Dalfra, Nicolucci, Lapolla, & TISG, 2009; Homko et al., 2012).  Despite the 
documented increased access that TM promotes as underpinned in these studies, no research has 
been conducted that unites TM, OUD, and rural pregnant women to address how primary care 
providers can incorporate TM into clinical practice for this patient population. Given that 
primary care is often the first entry point for maternity care as well as substance use disorders in 
northern BC, it is imperative that primary care providers have an evidence-informed approach to 
addressing accessibility of such services for their patients.  
The rationale for this review is that despite pregnant women with opioid use disorder 
being a promising priority population in northern BC to benefit from TM, to date the issue of 
how this might occur has not been formally examined. As such, this integrated literature review 
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seeks to answer the following question: Can nurse practitioners deliver effective1 and efficient2 
TM-based care for pregnant women with opioid use disorder living in northern BC?  
To begin, background information highlighting the significance of pregnant women with 
opioid use disorder living in northern BC will be presented. To provide further context, an in-
depth description of TM applications will be outlined. Given the focus of this paper is family 
nurse practitioner (NP) practice, the role and scope of practice of NPs as primary care providers 
in BC will be identified. Next, Chapter 3 will outline the aim, design and search strategy for this 
review, including a Table summarizing the search process. In Chapter 4 a quality appraisal and 
synthesis of the relevant studies will be conducted, followed by a discussion of their significance 
in context of macro, meso and micro-level health care service delivery in Chapter 5. 
Recommendations that target policy, organizational, and patient level of health care service 
delivery in the context of primary care services will be identified, as well as suggestions for 
implementation will be offered. Finally, the limitations of this paper will be presented and areas 
for further research and consideration for practice will be highlighted.   
                                                 
 
1 Effective outcomes: appropriate health care intervention; patient safety/risks; patient acceptability; clinical 
outcomes (NIFTE, 2003). 
2 Efficient outcomes: timeliness of health care intervention; reduced patient travel; and increase access to care 
(NIFTE, 2003) 
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Chapter Two 
Background 
Opioid Use Disorder 
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as 
fentanyl, and pain relievers such as oxycodone, hydrocodone, codeine, morphine, and many 
others. Opioids can be injected or taken in pill form. Opioid analgesics can be misused (taken in 
a different way or in a larger quantity than prescribed) or taken without a prescription. Regular 
use of these medications, – even as prescribed by a health care provider, – can lead to 
dependence and when misused, opioids can lead to overdose and death. British Columbia has 
one of the highest opioid death rates in Canada with over 15 per 100,000 deaths reported during 
2016 (Government of Canada, 2016). In part, this is due to the recent emergence of fentanyl 
being used to replace or dilute heroin or other illicit opioids which contributes to a significantly 
higher risk for overdose (BCCSU, 2017). As a result, in April 2016, the opioid crisis was 
declared a public health emergency by BC’s health officer (BC Gov, 2016).   
Current research is showing a recent shift in health care language around opioid use that 
highlights the stigma attached to classifying opioid use as abusive, addictive, and dependent 
behaviour, since these labels can infer blame. These behaviours are components of substance use 
disorder as highlighted in The Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5) (American Psychiatric Association, 2013). The replacement of the terms opioid 
abuse and opioid dependence with the term opioid use disorder is in line with recognising the 
condition as chronic thereby including episodes of remission or exacerbation (Schuckit, 2016).  
Opioid use disorder (OUD) is a pattern of opioid use characterized by tolerance, craving, 
inability to control use, and continued use despite adverse consequences. OUD is diagnosed by 
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primary care providers (physicians and nurse practitioners) and is based on specific criteria such 
as unsuccessful efforts to cut down or control use, as well as use resulting in social problems and 
a failure to fulfill obligations at work, school, or home (American Psychiatric Association, 
2013). Appendix A outlines the full criteria for a diagnosis of OUD. These issues are further 
complicated during pregnancy because the window of opportunity for obtaining treatment during 
pregnancy is small (nine months) and pregnant women with OUD tend to seek prenatal care late 
in pregnancy or not at all (Finnegan, 2013; SOGC, 2017b). Since the focus of this paper is 
gender specific, the characteristics of OUD in women are explored with a more specific focus on 
pregnancy in the next section. 
OUD in Pregnancy 
Understanding the prevalence of OUD in pregnancy is a significant issue since this has 
direct implications for service delivery. In the U.S., the prevalence of drug use was 6.7% while 
during pregnancy this was 4.4% (Substance Abuse and Mental Health Services Administration, 
2011). In 2012, one in six women (17%) in Canada used opioids, with approximately 5% of 
users reporting misuse of these drugs (0.9% of the total population) (Government of Canada, 
2011). Results from the Canadian Maternity Experiences Survey (2009) indicated that 
approximately 7% of women reported using drugs, including opioids in the three months prior to 
pregnancy and 1.0% reported using drugs during pregnancy (Public Health Agency of Canada, 
2009). At present, there are no published prevalence rates for opioid use among pregnant women 
in BC. Due to inconsistent data reporting between illicit and prescription opioid use and the 
stigma and fear of child apprehension associated with reporting substance use in pregnancy, 
actual prevalence rates are most likely higher (Finnegan, 2013; SOGC, 2017a). 
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In BC, women with OUD frequently have complex health and social needs involving 
physical and mental health issues, history of violence, trauma, chronic pain, unemployment and 
homelessness (Center for Addictions Research BC, 2010). Through colonization, colonialism, 
racism, and discrimination, Indigenous peoples in northern BC continue to experience systemic 
inequities that result in poorer health outcomes (Reading & Wien, 2009). These inequities 
greatly affect pregnant women’s opportunities and ability to access, respond to, or succeed with 
treatment approaches for OUD during this vulnerable time.  
While current prevalence rates in northern BC for pregnant Indigenous women using 
substances has not been made available, preliminary data for 2016 indicates the rate of overdose 
and death from opioids among Indigenous people far exceeded non-indigenous rates across BC: 
Indigenous people are five times more likely than non-Indigenous populations to experience an 
overdose and three times more likely to die of an overdose (First Nations Health Authority, 
2017).  Across BC, overdose events have disproportionately affected Indigenous women when 
compared to their non-Indigenous counterparts (First Nations Health Authority, 2017). 
OUD in pregnancy is an issue that may disproportionately impact Indigenous women 
living in northern BC, however focusing solely on this population is outside the scope of this 
review. To make specific recommendations for this population requires an Indigenous lens from 
an Indigenous researcher otherwise we are at risk of reinforcing past colonial approaches that 
contributed to the structural inequities that exist today. Thus, this review will focus on the overall 
population of northern BC while recognizing the Browne, Varcoe, Ford-Gilboe, and Wathen 
(2015) equity-oriented approach to primary health care services (inequity-responsive care, harm 
reduction, trauma- and violence-informed care and culturally safe care) is one that can benefit all 
rural pregnant women with OUD living in northern BC.   
9 
 
  
Table 1 outlines some key barriers that are known to affect access to treatment for 
pregnant women with OUD and deserve consideration by those offering treatment or any 
primary care to rural prenatal women with OUD.  
Table 1. Barriers to Treatment for Pregnant Women with OUD. 
Psychosocial factors: 
    Shame, stigma, guilt, lack of family support, partner with SUD, fear of losing children,  
    violence, trauma, culture 
Systemic factors: 
    Lack of appropriate treatment services for pregnant women, negative attitudes of health care  
    providers, transportation, child care 
Biological process factors: 
    Shelter, food, clothing, employment 
 
Source: Center for Addictions Research (2010); Finnegan (2013); Jackson & Shannon (2012); SOGC (2017c).  
 
In addition to treatment barriers, OUD in pregnancy presents certain health risks. The 
risks associated with opioid use for mother and fetus can vary depending on the type of 
substance being used, duration, and frequency of use. However, it can be said that untreated 
OUD has been associated with risk-taking behaviour leading to higher rates of blood borne 
pathogens such as HIV, hepatitis, and other sexually transmitted infections, as well as preterm 
delivery, low birth weight, and stillbirth (SOGC, 2017c; Vuvinovic et al., 2008). Neonatal 
abstinence syndrome (NAS), a drug withdrawal syndrome, commonly occurs after in utero 
exposure to opioids. In 2009-2010, 0.3% of all infants born in Canada experienced NAS 
(Canadian Institute of Health Information, 2012). The incidence of NAS in Ontario has increased 
from 0.28 cases per 1,000 births in 1992 to 4.29 cases per 1,000 births in 2011, representing a 
15-fold increase (Turner et al., 2015). It can, therefore, be inferred that the increased prevalence 
of NAS reflects the current prevalence of the opioid use epidemic; however, further research in 
northern BC of the current prevalence of OUD among pregnant women is needed.   
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NAS is characterised by respiratory, gastrointestinal, central nervous system, and 
autonomic symptoms that can lead to respiratory distress, increased muscle tone, tremors, and 
seizures, poor feeding, vomiting, regurgitation, diarrhea, and sweating (SOGC, 2017c). 
Estimates show that 55 to 94% of infants display withdrawal symptoms (Hudack & Tan, 2012; 
McQueen & Murphy-Oikonen, 2016; SOGC, 2017c). Often neonates affected by NAS will have 
longer hospital stays and need treatment with a number of different medications to manage their 
withdrawal symptoms. In turn, the separation of mother and infant due to the need for NAS 
treatment can also lead to disturbances in mother-to-infant attachment (Finnegan, 2013). Another 
important consideration is that any regular, daily antenatal opioid exposure (e.g. heroin or 
methadone) can produce NAS complications. However, studies have shown benefits to opioid 
treatment such as methadone during pregnancy including: increased prenatal care; longer 
gestation; increased birth weight; and increased rates of infants discharged home in the care of 
their mothers (SOGC, 2017c). For these reasons, pregnant women can often be more motivated 
and ready to make a change during pregnancy (SOGC, 2017c).  
Handelsman, Stein, and Grella (2005) reported that the strongest predictors of treatment 
readiness for people with substance use disorder were in those that had individual motivating 
factors driving a need to seek treatment. Studies show that earlier intervention is key to 
minimizing the potential harms of opioid use to mother and fetus (Jumah et al., 2015; SOGC, 
2017c).  Evidence also suggests that longer duration of exposure in treatment is associated with 
increased post-treatment outcomes such as decreased opioid use and increased social 
productivity (Parkes & Reist, 2010). Therefore, motivation and readiness for change is a key 
component to the delivery of health services that optimize engagement, care, and treatment in 
pregnant women with OUD. In turn, it is imperative that treatment options are available to 
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women when they are ready. TM may help to further improve accessibility for rural women, as 
they will not have to wait for their provider to return to the community nor will they have 
concerns about the comfort level of their provider with OUD treatment in pregnancy. The 
following section outlines treatment options for pregnant women with OUD. 
Opioid Agonist Treatment in Pregnancy 
A number of empirically supported treatments exist for OUD in pregnancy, such as methadone 
and buprenorphine (Jumah et al., 2015). Table 2 outlines current Canadian guidelines for 
antenatal management of OUD adapted from Jumah et al. (2015).  
Table 2. Management of OUD in Pregnancy 
• Methadone maintenance therapy should be started for all women with opioid 
dependence in pregnancy. 
 
• If methadone is not available, maintenance therapy should be started with 
buprenorphine. 
 
• If methadone and buprenorphine are not available, maintenance therapy should be start 
with slow-release morphine. 
 
• If a woman is already receiving buprenorphine plus naloxone maintenance therapy 
before pregnancy, she may continue to do so during pregnancy or change to 
buprenorphine alone if available.  
 
• Detoxification should only be used at the patient’s request. The patient should be 
counselled about the high failure rate of detoxification, the risks of overdose with 
failure of detoxification and the option to start maintenance therapy at any point should 
she relapse.  
 
• All pregnant women with opioid dependence should be offered maintenance therapy 
and rehabilitation services postpartum. 
 
• Methadone, buprenorphine (Subutex), buprenorphine + naloxone (Suboxone) and 
slow-release morphine (Kadian) are all available in Canada.  
 Source: Adapted from: Jumah, Graves, & Kahan (2015) 
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The BCCSU (2017) and CRNBC (2017a) use the term “opioid agonist  treatment” (OAT) 
to include the use of methadone and buprenorphine for maintenance treatment. Regardless of the 
prescribing provider, it is important to consider that OAT requires a collaborative approach in 
order to meet the complex needs of pregnant women. The most recent guidelines from the 
BCCSU (2017) and SOGC (2017c) recommend consulting the RACE3 team or an addiction 
specialist for OAT in pregnancy.  
OAT is widely regarded as both a highly effective treatment for opioid dependence and 
an evidence-informed harm reduction intervention to prevent the transmission of blood-borne 
pathogens (Office of the Provincial Health Officer, 2014). Current evidence suggests that OAT 
and obstetrical care result in less overall substance use, improved prenatal care, and lower rates 
of obstetrical complications which results in improved outcomes for mother and fetus (SOGC, 
2017c). However, the effectiveness of BC’s OAT system depends on an interprofessional 
approach with three key components: prescribing, dispensing, and psychosocial services and 
supports (Office of the Provincial Health Officer, 2014).  
Until recently, two professional regulatory bodies were responsible for the prescribing 
and dispensing components of the OAT system: College of Physicians and Surgeons of British 
Columbia (CPSBC) and College of Pharmacists of British Columbia (CPBC). As of February 14, 
2018, a third professional regulatory body has now been approved for induction and 
continuation/maintenance prescribing of OAT: The College of Registered Nurses of British 
Columbia (CRNBC) for nurse practitioners (CRNBC, 2018). The registrants for the three 
regulatory bodies in BC (physicians, pharmacists, and nurse practitioners) must meet specific 
                                                 
 
3 RACE: Rapid Access to Consultative Expertise via telephone for health care professionals 
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training and certification requirements to be eligible to prescribe/dispense opioids for 
maintenance purposes.  
Prescribing OAT is a gradual process requiring patients to be seen weekly to monitor 
treatment response.4 Methadone requires additional monitoring as it is initially prescribed as 
daily witnessed doses ingested under the supervision of a pharmacist until patients demonstrate 
stability5 (approximately 12 weeks). After stability has been determined then patients may 
choose to negotiate carries (or take-home doses) of OAT (BCCSU, 2017). Full coverage for 
methadone and buprenorphine is available to individuals covered under the following plans: B.C. 
Income Assistance (Plan C); Fair PharmaCare (those who do not have a deductible or family 
maximum); Non-Insured Health Benefits Plan; and most recently Plan G, BC PharmaCare’s 
Psychiatric Medications Plan (BCCSU, 2017). The government of BC has taken recent action to 
improve access to OAT services by providing full health care coverage along with the necessary 
regulatory and policy changes towards prescribing privileges. TM might further help to improve 
access by offering new innovative ways of delivering OAT to rural communities.   
Thus far, evidence has shown that OUD in pregnancy is a significant issue in BC that has 
detrimental medical, social, and legal consequences for mother and fetus. Evidence-informed 
treatment for pregnant women with OUD exists and access is improving through various policy 
levers (BCCSU, 2017; Jumah et al., 2015; SOGC, 2017c). For rural women, however, OAT 
                                                 
 
4 For safety reasons patients are monitored weekly while adjusting dose due to pharmacokinetic properties of 
methadone (long half-life, slow bioaccumulation) and the high degree of individual variability in absorption rates, 
metabolism, potency and cross-tolerance with other opioids (BCCSU, 2017).   
5 Stability defined as: clean urine drug screens for 12 weeks; stable methadone dose for 4 weeks; social, cognitive 
and emotional stability; ability to safely store methadone at home; no signs of injection drug use (BCCSU, 2017). 
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services are often difficult to access or are non-existent. The following section will address the 
issues of rural access to OAT services in British Columbia (BC).  
Rurality 
In 2011, with a population of over 35 million, 19% or 6 million Canadians lived in rural 
and remote communities across the country (Statistics Canada, 2011). Likewise, in BC, 14% 
(609,000) of the provinces’ population resides in rural areas (Statistics Canada, 2011). BC is 
represented by five Regional Health Authorities: Fraser, Interior, Northern, Vancouver Coastal, 
and Vancouver Island; and two province-wide health authorities: Provincial Health Services 
Authority and First Nations Health Authority (Government of BC, 2017). Living in rural BC 
presents a number of challenges to delivering health care services. These challenges stem from 
multiple factors: geographically dispersed, long distances to urban centers, low population 
densities, less available health care providers, and inclement weather conditions (BC Ministry of 
Health, 2015). Each of these factors are pronounced in northern BC coupled with the fact that 
rural residents are more likely to experience poorer health outcomes as often linked to challenges 
with social determinants of health, in relation to those in urban areas (Reading & Wien, 2009). 
However, rural residents are also more likely to report a strong sense of community belonging 
compared to urban residents (Canadian Institute for Health Information, 2006), which may play a 
key role in program development for rural communities. 
The Northern Health Authority6 represents the greatest landmass with the fewest people 
per square kilometer (Figure 1 and 2) resulting in OAT being less accessible compared to all 
other health authorities. This is reflected in significantly fewer prescribing physicians, dispensing 
                                                 
 
6 Northern Health Authority can be referred to as NHA, Northern Health, and NH. For the purposes of this paper 
Northern Health will be used. 
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pharmacies, and less OAT patients dispersed over large geographical areas in Northern Health 
compared to other regions in the province (Office of the Provincial Health Officer, 2014). 
Appendix B compares availability of OAT providers by health authority. 
Therefore, with fewer prescribing/dispensing health care professionals, communities with 
greater isolation, and very low population densities, it may be difficult to locally support OAT 
for pregnant women (SOGC, 2017b). Concurrently, a lack of training in the treatment of 
addiction and pregnancy and providers’ discomfort with OAT in pregnancy, contributes to wide 
variations in the quality and availability of care for these women (Jumah et al., 2015). Therefore, 
understanding the setting where pregnant women with OUD reside may offer valuable insight 
into accessing treatment.  
16 
 
  
Figure 1. Regional Health Authorities 
 
Source: Government of BC (2017) 
Figure 2. BC Population per Square kilometer 
 
Source: Government of BC (2017) 
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In an analysis of rural definitions, du Plessis, Beshiri, and Bollman (2002), reported that 
“a community with a given set of distance and density parameters will have different 
opportunities depending upon the population size and the population density of the region in 
which the community is located” (p. 33). For this reason, understanding the degree of rurality is 
vital for determining the level of services required to support pregnant women with OUD.  
Defining rural is a complex process that has major implications for policy development, 
program planning, and funding models; all of which affect accessibility of OAT services for 
rural women living in BC. While the degree of rurality is an important consideration in the care 
and management of women with OUD, detailed examination of this process is outside the scope 
of this paper. However, understanding access to services in a rural context is significant since 
this has direct implications for program planning and service delivery. Therefore, du Plessis, 
Beshiri, and Bollman’s (2002) “rural and small town” Canadian benchmark definition will be 
used to guide this paper. Rural and small town refers to the population living outside the 
commuting zones of larger urban centers of 10,000 or more (du Plessis et al., 2002). While the 
authors acknowledged that the appropriate definition should be determined by the question at 
hand, they also believed that having a benchmark definition for understanding Canada’s rural 
population would provide analysts with a good starting point (du Plessis et al., 2002). 
Many rural communities in northern BC have extremely low population densities, thus it 
is unrealistic to believe that all specialized services can be delivered locally in these 
communities. Nonetheless, it is important that rural pregnant women have access to services 
when they are ready that reflect high quality patient-centered care. This includes timely access to 
the following: knowledgeable OAT prescribers in pregnancy; dispensing pharmacies; providers 
to witness doses if requiring daily methadone administration; and support services (laboratory, 
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mental health, and counselling). In addition to the above prescribing, dispensing, and support 
services required for rural delivery of OAT, an equity-oriented approach must also be 
considered. Therefore, to assist pregnant women with OUD who do not have locally available 
services to support OAT, other options should be considered. Of these, TM is an option that 
deserves further examination. TM has been explored in the literature as a means to improving 
access to health services in rural areas by providing a way for primary care providers located in 
urban areas to deliver care to rural patients in distal locations (Grubaugh, Cain, Elhai, Patrick, & 
Frueh, 2008). A more detailed account of TM is given in the following section. 
Telemedicine 
Definition. TM is a relatively new modality for health care delivery that aims to address 
some of the geographical challenges facing rural populations. By increasing health care access, 
TM has the potential to enhance health outcomes for populations that otherwise would not 
receive timely access to services (Fraser et al., 2017). This has major implications for pregnant 
women living in northern BC with OUD because timelier treatment has the potential to 
significantly reduce morbidity and mortality for mother and fetus (Finnegan, 2013).  
TM and telehealth are often used interchangeably, however telehealth is more of an 
umbrella-term that encompasses a broad range of applications including tele-education, 
professional development, or clinician-to-clinician encounters and the term TM is more 
applicable to primary care services that focus on practitioner-patient encounters (Doctors of BC, 
2014). Numerous terms are used to describe TM, the most common of which are asynchronous 
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and synchronous. Asynchronous TM or store-and-forward7 involves the exchange of pre-
recorded data between two or more individuals at different times (WHO, 2010). In contrast, 
synchronous TM or real time8 requires individuals to be simultaneously present for the exchange 
of information, such as in the case of videoconferencing (WHO, 2010). In both asynchronous 
and synchronous TM, information may be transmitted using a variety of sources, such as text, 
audio, video, still images, internet-based platforms, or remote patient monitoring.9 These terms 
are often used interchangeably and without precision. 
TM is defined by organizations that include the World Health Organization (2010), 
Institute of Medicine (1996), The College and Physicians of British Columbia (CPSBC, 2015) 
and College of Registered Nurses of BC (CRNBC, 2017). Appendix C compares the different 
definitions of TM. Although differences of opinion exist between the organizations, there 
appears to be some agreement that TM involves providing care at a distance via technological 
innovations. CPSBC (2017) use the term to include access to primary care services. Since the 
central focus of this paper involves the delivery of primary care services, the term TM will refer 
to “The provision of medical expertise for the purpose of diagnosis and patient care by means of 
telecommunications and information technology where the patient and provider are separated by 
distance” (CPSBC, 2015). In addition to the CPSBC (2015) definition and for the purposes of 
this review, TM will refer to the following: health care professionals located in urban areas 
(providing site) delivering care to rural patients in distal locations (receiving site) via two-way, 
                                                 
 
7 Store-and-forward: transmission of recorded health history such as pre-recorded videos and digital images (x-
rays). 
8 Real time: Live video: two-way interaction between a patient and a provider using audiovisual technology.  
9 Remote patient monitoring: patient health data that is transmitted to a provider for tracking and monitoring a 
health condition (glucose monitoring in diabetes). 
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interactive videoconferencing. It may be that having a unified definition of TM, in the context of 
primary care services, will improve buy-in for both providers and patients, as well as promote a 
better understanding of its benefits.  
Perceived benefits. The benefits of TM have been well documented in the literature and 
include more convenient services, less costs attributed to reduced travel, increased quality in care 
due to more timely and coordinated services, reduced health system utilization, and improved 
access to health care services for rural populations (Canada’s Health Informatics Association 
[COACH], 2015; Canada Health Infoway, 2011; Romanow, 2002; WHO, 2010). 
Due to the perceived benefits, TM has been integrated into various clinical practice 
settings with the intention of improving access, quality, and productivity of services for rural 
populations, including pregnant women (Abrans & Geier, 2006; Dalfra et al., 2009; Hod & 
Kerner, 2003; Homko et al., 2012; Kerner et al., 2004; Rashiah et al., 2006; Vinals et al., 2005).  
Likewise, in substance use disorder, internet web-based platforms have been used to provide 
counselling for those that would otherwise not be able to access services (Campbell, Miele, 
Nunes, McCrimmon, & Ghitza, 2012; Copeland & Martin, 2004; Rose, Skelly, Badger, Naylor, 
& Helzer, 2012).  
However, despite the vast amount of studies indicating the benefits of TM, many 
systematic reviews have reported only a small evidence base supporting the use of the modality. 
In a systematic review of reviews of 80 heterogeneous studies (Ekeland, Bowes, & Flottorp, 
2010), 21 studies reported TM is therapeutically effective, reduces health service utilization, and 
is technically effective; 19 studies concluded that TM is promising but the evidence is 
incomplete; and 22 studies found that evidence is limited and inconsistent. Two systematic 
reviews reported a lack of evidence supporting the effectiveness in improving clinical outcomes 
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for diabetes due to diversity in design of the studies: type of technology employed 
(synchronous/asynchronous); differing health conditions; and evaluation of health outcomes 
(Farmer, Gibson, Tarassenko, & Neil, 2005; Verhoeven et al., 2007). In two other systematic 
reviews, McLean et al. (2011) and Flodgren, Rachas, Farmer, Inzitari, and Sheppard (2015) also 
reported diversity in study design contributed to weaker evidence: three out of 10 studies and 11 
out of 93 studies, respectively, reported measuring patient satisfaction and of those the majority 
were measured with poorly constructed and unvalidated surveys.  The Agency for Healthcare 
Research and Quality (AHRQ) also reported that although TM research offers a wide range of 
studies in a variety of clinical settings using different modes of delivery, the body of evidence 
supporting its use has been slow to evolve (AHRQ, 2008). Despite this, TM continues to expand 
in BC. See Figure 3 for a provincial map of communities in BC with TM capabilities.  
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Figure 3. TM Facilities in BC 
 
Source: PHSA (2017). 
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As noted by Figure 3, TM in BC is active throughout the province indicating a high level 
of technical readiness. Technical readiness has been shown to be an important consideration for 
TM implementation and on-going sustainability of services (Jennett et al., 2003; NIFTE, 2003; 
Scott et al., 2007). Despite adequate technical facilities, TM services in BC remain fragmented. 
This may be partly due to the considerable overlap of services provided by three of BC’s health 
authorities – Northern Health, Provincial health Service Authority, and First Nations Health 
Authority. As TM services in BC continue to grow, there is no consensus on the design, 
implementation, and evaluation of TM programs or services. This is not an uncommon finding in 
TM research, and may be due to unclear definitions, different modes of delivery, various 
contexts to which TM is applied, and various user involvement or interests. For these reasons 
TM has been recognised as a complex intervention (McLean et al., 2011; Salisberry et al., 2016); 
therefore, in order to address the question this review seeks to answer, an overview on complex 
interventions and how this applies to TM is warranted.  Only by addressing TM as a complex 
intervention can we begin to understand the key components that contribute to the effective and 
efficient design, implementation, and evaluation of TM services.  
Complex Interventions. The Medical Research Council (MRC) created a framework for 
designing, implementing, and evaluating complex interventions to improve health (Craig et al., 
2006). Complex interventions are described by Craig et al. (2006) as interventions that contain 
several interacting components that require clear definitions prior to implementation such as: 
classifying the variant forms of the intervention; clearly defining the intervention; and 
establishing the context and environment in which the intervention is being undertaken. TM 
clearly contains several interacting components that are consistent with being a complex 
intervention. In order to apply the findings of this review attention to context is crucial: “what 
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works in one setting may not be as effective, or may even be harmful, elsewhere” (Craig et al., 
2006, p. 14). For example, OAT for pregnant women may be completely different in a 
community of 500 people that is situated 600 km away from basic health care services compared 
to communities with increased population density and closer proximity to services. Therefore, 
every attempt was made to establish the various contexts of TM as this has direct implications 
for the safety of pregnant women with OUD. As set out by the MRC framework (Craig et al., 
2006), the process of a complex intervention from development through to evaluation includes a 
wide range of key components important to the successful implementation of TM. Figure 4 
summarizes the main stages of this process. 
Figure 4. Key Components of the Development, Implementation, and Evaluation Process 
 
  
 
Source: Craig et al. (2006) 
The MRC framework as depicted in Figure 4, begins with developing a theoretical 
understanding of the likely process of change whereby the intervention (such as TM) can be 
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reasonably expected to have a worthwhile effect (Craig et al., 2006). Therefore, the development 
of TM needs to begin with identifying the evidence, identifying/developing theory, and 
modelling the process and outcomes. Indeed, this process highlights the importance of 
identifying readiness for change. In the literature, it has been suggested that assessing for 
readiness prior to implementation is key to the success and sustainability of new innovations 
such as TM (Jennett et al., 2003). The next section will move on to consider how readiness can 
be assessed for complex interventions like TM.    
Readiness. Readiness for innovation and change has been well-explored in the literature: 
the freezing and unfreezing model of change (Lewin, 1947/1951); eight critical components of 
generating transformation in organizations (Kotter, 2012); the movement of a community or 
individual from pre-contemplation to contemplation (Prochaska & DiClemente, 1982); and the 
diffusion and infusion of innovations (Rogers, 1983). In repeated studies looking at TM 
implementation, readiness has been shown to be the foundation of successful implementation 
(Jennett et al., 2003; Labiris & Petounin, 2004; Muttitt, Vigneault, & Loewen, 2004). TM 
readiness has been defined “as the degree to which users, healthcare organizations, and the health 
system itself, are prepared to participate and succeed with telehealth implementation” (The 
Alliance for Building Capacity (ABC), 2002, p. 29).   
Based on the principles of the ABC (2002) model of care, Jennett et al. (2003) developed 
a readiness framework for implementing TM in rural/remote locations in Canada whereby 
practitioners, organizations, and patients were assessed for readiness in the context of receiving 
or providing TM-based services (Jennett et al., 2003). Types of readiness identified were core 
readiness, engagement, structural readiness, and non-readiness (Jennett et al., 2003). Appendix D 
outlines the factors affecting TM readiness within four domains (public, patient, practitioner, and 
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organization) and the three types of readiness (core, engagement, and structural). The fourth type 
of readiness was non-readiness and was characterised by lack of need for change or a failure to 
recognize such need (Jennett et al., 2003). 
 In Jennett et al.’s (2003) seminal work, it was found that readiness for change was an 
integral and preliminary step in the adoption of TM and the level of success was dependent upon 
the extent to which practitioners and patients alike, perceived the change as needed. As 
pregnancy is a time when women are more motivated to make a change (SOGC, 2017c), and 
therefore may be more willing to try TM, understanding readiness in the context of rural 
populations in BC is critical; especially, given their strong sense of community belonging 
(Canadian Institute for Health Information, 2006). Thus, ensuring an acceptable level of 
readiness can offer more seamless transitions from in-person services to TM care at a time when 
women are at their most vulnerable. Part of achieving buy-in of services from TM users is 
adequate preparation. When users are not prepared, fear and insecurity can be barriers to 
successful implementation (Jennett et al., 2003) and for populations that are already vulnerable, 
this creates additional barriers.  
In the 15 years since the development of Jennett et al.’s (2003) readiness framework, it 
appears that TM programs in BC may have largely been implemented without addressing 
readiness as evidenced by the PHSA telehealth portal (PHSA, 2018). BC TM programs, as 
commonly developed through this portal, are lacking the translation piece from program into 
clinical practice. Providers connect via an on-line request form and as long as the sites have 
technical infrastructure, TM is ready to implement. The provincial wide portal stipulates, best 
practice for TM providers requires the same ethical considerations and are held to the same high 
standards of quality safe care as in-person services (PHSA, 2018). However, this does not 
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account for situations where geographic location prevents the standard expected in traditional 
face-to-face care such as the delivery of OAT for pregnant women living in rural areas with 
limited access to prescribing, dispensing, and support services. National guidelines for TM 
design, implementation, and evaluation exist but they have yet to be integrated into BC TM 
programs. The following section will briefly outline two national TM guidelines that will help 
address the effectiveness and efficiency of TM applications that is guiding this review.     
TM Guidelines. In 2003, The National Initiative for Telehealth Framework of 
Guidelines (NIFTE) was developed to assist individuals and organizations with the development 
of TM policy, procedures, guidelines, and/or standards related to five main areas: Clinical 
practice guidelines; clinical standards; human resources; organizational readiness; organizational 
leadership; and technology and equipment (NIFTE, 2003). At the time, TM projects and 
programs were being implemented with little attention towards quality and outcomes related to 
the delivery of TM services. Instead, TM was being described as one of the most promising 
interventions for improving access to rural services (NIFTE, 2003; Romanow, 2002). The 
NIFTE (2003) guideline was designed to provide a benchmark for on-going provision of quality 
TM services.  
In 2007, the benefits of TM had yet to be validated. Identifying and measuring specific 
outcomes of TM services had remained poorly executed. Therefore, the National Telehealth 
Outcome Indicators Project (NTOIP) was designed to provide a Canadian consensus approach to 
identification and definition of outcome indicators for evaluation in TM (Scott et al., 2007). The 
recommendations were based on the work that was conducted through an environmental scan, 
systematic literature review, a national expert’s workshop and a consensus process (Scott et al., 
2007). At the time of the inception of the project, there was no regional, provincial, or national 
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agreement on which quantitative or qualitative outcomes measures were appropriate when 
evaluating TM applications (Scott et al., 2007). Therefore, NTOIP identified four evidence-
informed outcome indicators specific to TM applications: quality, access, acceptability, and cost 
(Scott et al., 2007).   
Although old, the NIFTE (2003) and the NTOIP (Scott et al., 2007) are not outdated 
because they continue to serve as a useful point of reference that meet or exceed newer 
international guidelines. The American Telemedicine Association (ATA) implemented core 
standards for TM operations in 2007 that continue to provide overarching guidance for updated 
health-specific guidelines in TM (ATA, 2007): telemental health (ATA, 2010); teleburn (ATA, 
2017a); and telestroke (ATA, 2017b). Of note, the ATA (2007) also incorporates the NIFTE 
(2003) in its guideline development. 
At present, both documents (NIFTE, 2003; NTOIP, 2007) have yet to be adopted into 
mainstream evaluation practices for TM in Canada despite being developed over a decade ago. 
There are several possible explanations for this. First, there is no consensus on the definition of 
TM. Second, regulatory bodies emphasize that TM does not alter the professional regulatory 
requirements around the provision of appropriate care (CPSBC, 2015; CRNBC, 2011); therefore, 
others may perceive TM guidelines as unnecessary. Lastly, health authorities are not currently 
promoting the use of these national guidelines to their full extent which implies TM is being 
viewed as a routine service. The NIFTE (2003) clearly state that TM has yet to be considered a 
routine service in the delivery of health care.  
TM has the potential to improve access to services such as OAT for rural pregnant 
women; however, as with any health care service, TM patients must be assured of receiving high 
quality, acceptable, and safe care. By establishing a process for clearly defining TM services, a 
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solid foundation can be developed to which all involved in TM can refer (Scott et al., 2007). 
Currently, there is no consensus for the evaluation of TM services or the benefits of receiving 
such care in BC. 
Recommendations from the NIFTE (2003), NTOIP (Scott et al., 2007), and Jennet et al. 
(2003) guidelines provide complementary understanding of quality TM service provision, which 
is necessary to interpret the findings of this review.  
Another important consideration to implementation of TM services is human resources 
and the role family nurse practitioners (NP) have in providing TM services in BC for prenatal 
women with OUD. Understanding NP scope of practice is vital when considering how NPs will 
utilize TM-based services to ensure accessible, quality safe care for vulnerable populations in 
northern BC. NPs engaged in TM are accountable for practicing in accordance with CRNBC 
Standards of Practice, and all relevant BC and federal legislation (CRNBC, 2011). Therefore, 
consideration of what NPs could do regarding their scope of practice will be vital to answering 
the question this review seeks. The next section will briefly outline the scope of practice for NPs 
in BC related to the topic of interest in this review. 
Scope of Nurse Practitioner Practice 
A nurse practitioner (NP) is able to independently diagnose and treat certain diseases and 
conditions as specified by CRNBC's document Scope of Practice for Nurse Practitioners: 
Standards, Limits, and Conditions (CRNBC, 2017c). This includes providing prenatal care for 
patients at any time during the pregnancy prior to delivery. However, this is a professional 
decision influenced by maternal/fetal complexity and risk, individual provider competence in 
delivering prenatal care, and patient preference for a provider (CRNBC, 2018). Delivery is 
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outside of the scope of practice for nurse practitioners, therefore transfer of care to a physician or 
midwife is warranted.  
NPs also have the knowledge and skills to diagnose, provide treatment, and manage 
substance use disorders. New NP Standards, Limits, and Conditions specifically for induction 
and continuation/maintenance prescribing of OAT in OUD are now in effect (CRNBC, 2018b). 
Prescribing privileges will be granted to NPs that meet these standards as set out by CRNBC 
(2017b) and BCCSU (2017). This includes additional education for NPs prescribing OAT to 
have knowledge about OUD including treatment (OAT and psychosocial treatment 
interventions) and harm reduction strategies. NPs will need to obtain an exemption from Health 
Canada under section 56 of the Controlled Drugs and Substances Act before prescribing 
methadone (CRNBC, 2018b).  CRNBC will apply for this exemption on NP’s behalf when they 
submit their first order for methadone prescription pads. These standards, limits, and conditions 
do not apply to prescribing opioid agonists for pain or other symptoms (CRNBC, 2018b). 
Strengths NPs may bring to addressing the issues of OUD in pregnancy are two-fold. 
First, NPs endorse an interprofessional approach based on collaboration (CNA, 2011; WHO, 
2010). Evidence demonstrates that interprofessional collaborative models of health service 
delivery can positively impact the management and treatment of vulnerable populations with 
substance use disorder (Hardin, Kilian, & Spykerman, 2017) and that a variety of 
interprofessional groups play important roles in the delivery of OAT in BC including: 
physicians, specialists, nurses, social workers, pharmacists, mental health and substance use 
counselors, and others (Parkes and Reist, 2010).  
Second, one intent of the NP role is to increase access to primary care services for all 
British Columbians, including those that reside in rural and remote areas. As of February 28, 
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2017, there were 413 NPs practicing in the province of BC, up 74 from the previous year 
(CRNBC, 2017b). According to Helen Bourque, the NP lead in Prince George, 31 NPs are 
currently practicing in Northern Health (personal communication, January 25, 2018). This means 
that with an increase in provider numbers along with additional OAT specific prescribing 
privileges, there will be increased numbers of qualified NPs to respond to the opioid crisis in BC.  
 As front-line health care providers, NPs gain first-hand knowledge of the complexities of 
the socioeconomic conditions associated with vulnerable populations. This affords NPs an 
opportunity to influence the social and political trends that are shaping such inequities and move 
towards more socially responsive ways of delivering primary care (Browne & Tarlier, 2008).  
In BC, NPs continue to be implemented into new roles, and this may afford opportunities for 
uncovering new ways of working in primary care such as the use of TM services. Before 
embarking on any new innovation, primary care providers, including NPs, must determine the 
impact of the modality on delivering high quality and safe care to vulnerable populations such as 
pregnant women with OUD in northern BC. For the remainder of this review, the term primary 
care provider will refer to all providers working in primary care including NPs. The next step is 
to perform a comprehensive literature search drawing on established methods by Whittemore and 
Knafl (2005) to answer the research question. The methods used in this process will be described 
in the next chapter.  
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Chapter Three 
Methods 
In this chapter the aim and design method chosen for this literature review is explained. 
Rationale for the method used, identification of the research question, and an explanation of the 
search strategy are discussed.  
Aim 
This review was based on identification of a clear need for better guidance for primary 
care providers towards improving the timely access of medically appropriate care for pregnant 
women with OUD in rural BC. This review is highly relevant for NPs as the recent changes to 
NP Standards, Limits and Conditions allow for both the initiation and continuation prescribing of 
OAT (CRNBC, 2018b). NPs also have a clear mandate that encompasses health promotion, 
disease prevention, and illness management for some of the most vulnerable populations in BC 
(BC Charter, 2007; CNA, 2017; CRNBC, 2017c).  
The overarching research question this review seeks to address is: Can nurse practitioners 
deliver effective and efficient TM-based care for pregnant women with opioid use disorder living 
in northern BC? In order to answer this question and determine if NPs can provide this type of 
care effectively and efficiently, the following two sub-questions will be addressed: 
1) Does TM meet the same standards of care as face-to-face?  
2) Is community readiness an influencing factor for TM implementation? 
In order to answer the first sub-question, a comprehensive review of the literature 
focusing on a quality appraisal of the studies will be completed. For this review, the strength of 
overall evidence is most important when it is used for guiding practice changes. Given the 
population of interest in this review, changes in practice can greatly affect the lives of both 
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mother and unborn child. Therefore, addressing the level and quality of evidence is a critical 
piece of this review. The quality appraisal will be followed by a critical analysis of the relevant 
studies focusing on the key elements of TM that are foundational when comparing TM with 
face-to-face care. Therefore,  NIFTE (2003), NTOIP  (Scott et al., 2007), and du Plessis et al.’s 
(2002) National Benchmark Definition of Rural, will be used to guide this analysis. 
 NIFTE provide evidenced-informed guidelines for the provision of TM services that 
examine five main content areas related to TM: 1) Clinical Practice Guidelines (CPGs) and 
Outcomes; 2) Human Resources; 3) Organizational Readiness; 4) Organizational Leadership; 
and Technology and Equipment (NIFTE, 2003). In the context of BC, this review will focus only 
on the first two content areas to answer the first sub-question. As technology and equipment are 
well-established in BC, this will not be discussed. Although important, organizational leadership 
will not be included because this review is focusing on issues at the policy level in order to 
answer question one. Organizational readiness will be addressed in question two.  
 NTOIP was designed to provide guidance on specific outcome indicators for use when 
evaluating TM applications and include four categories: quality, access, acceptability, and cost 
(Scott et al., 2007). Although important, cost analysis is outside the scope of this review and will 
not be discussed. Therefore, the outcome indicators (quality, access, and acceptability) will be 
used to evaluate the relevant studies in terms of measurable outcomes.  
In summary, a quality appraisal approach to the literature search followed by a critical 
analysis of the relevant studies will consider these four evidence-informed key elements in light 
of TM capacity to deliver care that is at least equivalent to the standard expected in traditional 
health care delivery: assessment of clinical standards in relation to CPGs and TM; attention to 
the specific outcomes from each study as applied to TM; consideration of the nature and 
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description of rural within the context of TM; and attention to the mix of health care provider 
engagement in delivering and evaluating TM (du Plessis et al., 2002; NIFTE, 2003; Scott et al., 
2007). In conclusion, the quality appraisal and the four elements of TM will be used to assess the 
quality and quantity of evidence for determining if TM can provide comparable care to in-person 
services. The aim of this review will now move on to the second sub-question in this review.   
The second sub-question will be addressed using Jennett et al.’s (2003) TM readiness 
framework to identify the different degrees of community readiness discussed in the selected 
studies and to determine if this may be an influencing factor for TM implementation. This is of 
central interest for rural communities in BC because resources are limited and the benefits of TM 
have yet to be determined, which highlights the potential for harm to populations that have 
historically received fragmented and in some cases, culturally unsafe care. The central focus of 
this review is directed towards rurality because of the inequities that exist between BC’s urban 
and rural populations (Ministry of Health, 2015) and as a result NPs have a duty to provide 
equitable care to those that need it most (CNA, 2017). Much of BC is rural with small dispersed 
populations and with that comes challenges of fewer providers (Ministry of Health, 2015). 
However, increasing numbers of NPs in BC can help mitigate provider shortages along with new 
innovative ways of delivering primary care. TM-based care can provide access to services that 
otherwise may not exist for rural populations; however, if communities are not ready then a 
system promoting TM will need to overcome these challenges to succeed in delivering services 
to BC’s most at-risk populations.   
Design  
 A literature review can be considered a critical summary of research on a topic of 
interest. An integrated literature review was chosen as it permitted the inclusion of a wide range 
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of sources, including qualitative and quantitative data, methodologies which were perceived to 
be appropriate to answer the research question (Whittemore & Knafl, 2005). Therefore, this 
review is guided by Whittemore & Knafl’s (2005) method. According to the authors, an 
integrative review is one of the broadest types of research review methods and with the inclusion 
of both experimental and non-experimental data, it allows the reader to have a more in-depth 
understanding of the phenomenon of interest (Whittemore and Knafl, 2005). TM is a complex 
intervention that requires a variety of methods to capture the knowledge required to fully 
understand the intervention in the context of rurality, making an integrative review an ideal 
method to answer the question. 
 According to Whittemore and Knafl (2005), “data analysis in research reviews requires 
that data from primary sources are ordered, coded, categorized and summarized into a unified 
and integrated conclusion about the research problem” (p. 550). To start, relevant data was 
abstracted, analyzed, and summarized using a literature review matrix. Column headings in the 
matrix were guided by John Hopkins literature appraisal guidelines (2017) and Whittemore and 
Knafl (2005). Details of quality, reliability, strengths, and limitations of each article were 
summarized in a shortened version of the literature review in Appendix E. The matrix was 
modified accordingly as findings were presented in Table format within the body of this review 
where appropriate to help identify important information. The process of data analysis in this 
review included using a constant comparison method as recommended by Whittemore and 
Knafl, (2005). The studies were evaluated using the following strategies: overall quality, and 
identification of patterns, themes, variations and relationships. They were then further analyzed 
and synthesized using data display, data comparison, conclusion drawing and verification. 
Accordingly, the results from each study were displayed on a flip chart and common themes 
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were assigned a number and counted. The data were compared and then checked and rechecked 
for verification. Next, the search strategy will be described.  
Search Strategy 
 The importance of a thorough search strategy cannot be underestimated. A 
comprehensive search strategy ensures all relevant information and data is reviewed, which 
enables the author to extract applicable content to inform the research question. The literature 
search was conducted using the electronic online databases through the University of Northern 
British Columbia library: CINAHL (EBSCOhost), Medline (Ovid), and PubMed. These data 
bases were chosen as they are specific to many healthcare-related journals. The search terms 
were based on the research question and were combined using “AND” or “OR” and all MeSH 
terms were exploded in order to decrease risk of omitting important literature (Table 3).  
Table 3. Search Terms 
Telehealth OR telemedicine OR telehealthcare 
AND 
Rural OR remote OR rural health OR rural health services 
Limits: From the year 2005 to present 
 
A preliminary search suggested that TM research became more prominent around 2005, 
particularly in the case of videoconferencing. Therefore, 2005 was chosen as the starting point 
for this integrative review. Likewise, it was found that by adding the search term pregnancy, 
mental health, and/or substance use, results were narrowly confined to the use of TM in home-
monitoring or self-monitoring which is outside the scope of this question. Therefore, search 
terms were intentionally kept broad to capture the breadth and depth of the current literature on 
the use of TM for rural populations. By taking out the search term pregnancy, results now 
included both female and male populations. Again, to narrow this further to entirely female 
populations would have excluded valuable information helpful towards addressing the two 
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specific sub-questions as well as the overarching question which guided this review. Therefore, 
both male and female populations were included and although this was a recognized limitation, 
given the scant information available about rural pregnant women with OUD who had access to 
TM, the search was inclusive enough to consider populations that had similar health disparities, 
inequities, and/or higher risk medical conditions to the population of interest in this review such 
as chronic diseases, mental health disorders, substance use, pregnancy, or cancer related 
treatment. 
 The literature search strategy for this integrative literature review occurred in four stages, 
including (1) screening the titles of articles; (2) reviewing abstracts of articles; (3) reviewing full 
text of articles; and (4) applying exclusion (Table 4) and inclusion (Table 5) criteria to full text 
articles.  
Table 4. Exclusion Criteria 
• TM for palliative care (does not fall under health promotion, disease prevention, or 
primary care) 
 
• Papers published before 2005 
 
• Studies specifically directed at developing nations where primary care access and 
standards of health care are not generalizable to Canada’s health care system 
 
• TM delivered via telephone, internet-based platforms, home-monitoring devices, store 
and forward (e.g. glucose monitoring devices) 
 
• < 19 years of age 
 
• Languages other than English 
 
• If health care professionals delivering the care did not include one of the following: 
General practitioner (GP), nurse practitioner (NP), advanced practice nurse (APN), 
registered nurse (RN) or specialist.   
 
• If TM services included clinician-to-clinician encounters 
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Table 5. Inclusion Criteria 
• Published in English 
 
• Published from 2005 to present 
 
• Adults > 19 years old 
 
• Original research articles 
 
• Qualitative, quantitative, or mixed studies 
 
• Peer-reviewed journal articles 
 
• Mode of TM delivery had to include videoconferencing 
 
• Health care professionals delivering the care had to include at least one of the 
following: GP, NP, APN, RN, specialist 
 
• Studies based in any country, provided that primary care access and standards of care 
were similar to Canadian health care standards.  
 
• High risk health conditions/diseases/health disparities – Chronic diseases, mental 
health, substance use, pregnancy (EXCEPT palliative care) 
 
• Delivery of services must include clinician-to-patient care encounters 
 
• Published pilot projects 
 
• Grey literature in BC - studies specific to delivering TM care to rural populations 
 
 An unexpected finding of this literature search was the number of pilot projects. A 
decision to include these studies was made based on their utility of contributing to a deeper 
understanding of the topic for this review, provided all other inclusion/exclusion criteria were 
met.  
The combination of MeSH terms (Table 6) yielded 558 articles in the three selected 
databases. After duplicates were removed and titles and abstracts were screened, 23 articles were 
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selected, and full articles were read for inclusion/exclusion criteria. Eleven articles met the 
criteria for this review. Table 6 illustrates a summary of the full search process. 
Table 6. Search Strategy and Results 
CINAHL, Medline & PubMed  
Total records obtained from database searches 
n= 558 
Duplicates removed  n=5 
Titles & abstracts screened using inclusion  
& exclusion criteria   
n=553 
Records excluded  n=530 
Full text review for inclusion/exclusion  
Criteria 
n=23 
 
Records excluded  n=13 
Full articles selected for review  n= 11 
Total articles for review 
n= 11 
 
To conclude this section, the final sample for this integrative review included 11 articles 
from a wide variety of methods: randomized controlled trials, mixed-method study, qualitative 
interviews, and quantitative instrument development designs. The majority of studies were 
conducted outside of Canada: seven in the United States (U.S.) and two in Australia (Appendix 
F). These studies were considered suitable for inclusion in this review because rural populations 
in the U.S. and Australia experience significant health disparities compared to their urban 
counterparts (Australia Bureau of Statistics, 2011; Center for Disease Control and Prevention, 
2013) that are similar to Canadian and northern British Columbian rural residents (Ministry of 
Health, 2015).  
As determined by the inclusion/exclusion criteria, the study populations consisted of both 
men and women with various at-risk health conditions or populations with an increased risk for 
vulnerability due to health disparities and/or inequities (Appendix E): Nine studies included at-
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risk populations consistent with the population of interest in this review (HIV, Hep C, mental 
health, cancer screening and treatment, poor pregnancy prognosis, and abortion). Both HIV and 
hepatitis C (Hep C) are chronic diseases that have been associated with higher rates among 
pregnant women with OUD (SOGC, 2017c). Mental health disorders are known to often co-
occur with substance use and likewise, addiction is common in people with mental health issues 
which often entails similar treatments (National Institute on Drug Abuse, 2012). This is a topic 
well beyond the scope of this paper and is only presented to identify common features to the 
population of interest, thus indicating the studies were suitable for inclusion. Further, two studies 
(Holyk, Pawlovich, Ross, & Hooper, 2017; Ross, Yap, van der Nest, Martin, & Edie, 2016) 
included rural First Nations populations. Indigenous peoples living in remote rural communities 
face considerably poorer health outcomes, as often linked to challenges with social determinants 
of health, in relation to those in urban areas (Reading & Wien, 2009), thus indicating these 
studies were also suitable for inclusion.   
In the next chapter, the two sub-questions outlined previously will be addressed in order 
to answer the overarching research question. 
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Chapter Four 
Findings 
Quality Appraisal 
This section will begin with a quality appraisal of the relevant studies to answer the first-
sub-question: Does TM meet the same standards of care as face-to-face? Evaluating the quality 
of primary sources in the integrative review is a complex process, especially when the research 
designs are diverse, such as in this review. According to Whittemore and Knafl (2005) “no gold 
standard exists for evaluating and interpreting quality in research reviews” (p. 550). Further, the 
authors also state that in an integrative review with diverse empirical sources, it may be 
reasonable to evaluate methodological quality to determine if it is “a viable reason for the 
discrepant finding” (p. 550). As discussed earlier, the level and quality of evidence is critical for 
the population of interest in this review, especially when the findings can be used to guide 
changes in practice.   
Evaluating the quality of the literature was completed using the John Hopkins Nursing 
Evidence-based Appraisal Tool (2017). The tool was used as a guideline to address rigor, 
validity, and strength of evidence of each of the eleven articles. Permission was granted for use 
in this study. Appendix F outlines the appraisal tools used.  
To determine if TM can meet the same standards of care as face-to-face, study design and 
data collection methods were analysed and appraised below.  
Study methods. A variety of methods were employed by the authors of the selected 
studies to assess the use of TM-based care. Each has its advantages and drawbacks. Although 
measurable outcomes played a significant part in the quality appraisal of the studies, this will not 
be discussed in detail for this section other than to report on the reliability and validity of the data 
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collection methods used. An in-depth discussion of the clinical outcomes will resume in the next 
section on the key elements of TM.  
Two studies (Morland et al., 2010; Morland et al., 2015) used non-inferiority randomized 
controlled trial methods. The benefit of this approach is that non-inferiority trials aim to show 
that the new treatment is not inferior or “materially worse than the control” (U.S. Department of 
Health and Human Services Food and Drug Administration, 2016), in this case the comparator 
being face-to-face care. As NPs are responsible and accountable for providing safe and 
appropriate care (CRNBC, 2015; CRNBC, 2017c), TM-based services need to provide 
comparable outcomes to in-person care in terms of effective and efficient outcomes. The use of 
appropriate reliable and valid patient reported outcomes (PROs) were employed in Morland et al. 
(2010; 2015), see Appendix E for further details. The PROs were consistent with each study’s 
focus of providing evidence-based treatment of mental health disorders. This ensures that the 
instrument is not only measuring what it is supposed to but that it is providing dependable and 
accurate results. A major strength of these two studies (Morland et al., 2010; Morland et al., 
2015) was that there was strong evidence demonstrating that TM produced similar outcomes to 
in-person care using valid PROs with substantial follow-up (baseline, post treatment, 3-month, 
and 6 month) with participants.  
Validated veteran-specific satisfaction surveys were employed in both studies by 
Morland et al. (2010; 2015), however they were neither designed nor validated for TM which 
limits generalizability to other populations. Morland et al. (2015) also reported using a TM-
specific satisfaction survey designed by Frueh, Henderson, and Myrick (2005) but it has yet to be 
validated. Despite these limitations, Morland et al. (2010; 2015) reported sufficient sample sizes, 
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adequate randomized control of participants and consistent definitive conclusions, thus were 
rated of high quality.  
An exploratory-descriptive qualitative design was employed in three studies (Grindlay, 
Lane, & Grossman, 2013; Jhaveri, Larkins, Kelly, & Sabesan, 2016; Wyatt et al., 2013). This 
type of research is commonly used in situations that lack clear description or definition with a 
specific population which makes it a highly suitable method for evaluating the use of TM with 
at-risk rural populations. All three studies reported sufficient sample sizes, used either 
convenience or purposeful sampling methods, provided definitive conclusions based on 
appropriate data collection methods, thus were rated of high quality (see Appendix E for more 
details). A major strength in the quality of these studies was that they provided in-depth 
information on participant experiences as well as specific characteristics, such as locality (TM 
providers and patients) of TM-based services.    
A mixed-method approach was used in one study (Ohl et al., 2013). A major advantage 
of this approach is that it can capitalize on the strengths of both qualitative and quantitative 
methodologies to provide a more comprehensive understanding of complex interventions such as 
TM (Caffery, Martin-Khan, & Wade, 2016). For the quantitative evaluation, Ohl et al. (2013) 
used a quasi-experimental non-random one-group pre/ post-test design which was appropriate 
due to the given geography (limited availability of sample sizes with multiple dispersed rural 
locations). Response to treatment indicators reflected current professional practices, however the 
study included 17 different outcome measures whereby not all of the measures were a part of 
usual in-person care. This was reflected in several health screening measures (syphilis screening, 
vaccinations, tobacco and alcohol use, and depression) not being included in usual care but were 
later introduced as part of TM care. The authors acknowledged the discrepancy; however it 
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remains unclear if TM or other variables were responsible for the improvements in screening 
measures. Although this limitation affects the analysis of the article, the study is still included 
because it highlights the lack of valid measurable health outcomes in TM research; which is a 
problematic issue that has previously been identified in the literature (NIFTE, 2003; Scott et al., 
2007).  
Similar to the satisfaction surveys in Morland et al. (2010; 2015), a veteran-specific 
survey was also used in Ohl et al. (2013) which in turn limits generalizability to other 
populations. Limitations of the study included a lack of adequate power (Ohl et al. 2013), and 
not all participants were part of the same pre and post-test group, which threatened both internal 
and external validity. Due to these methodological flaws this study was rated as low quality, thus 
results must be interpreted with caution. However, the qualitative evaluation of this mixed 
method study provided several contributions and so remained in the review. 
For the qualitative evaluation of the mixed-method study, Ohl et al. (2013) employed 
appropriate qualitative data collection methods (Appendix E) and reasonably definitive 
conclusions based on participant experiences with TM use that included stigma and privacy, 
improved access and health care provider roles. Limiting the conclusions of this study was the 
lack of participants’ verbatim responses which increases confirmability between participant 
experiences and the explanation of themes. However, the in-depth program planning with 
patients and health care providers that took place before, during, and after TM program 
implementation was a clear strength because it assists organizations in “. . . defining their client 
population and their health-care problems, how these health-care needs can be met, and why 
telemedicine is the best way of meeting these needs” (Jennett et al., 2003, p. S2:28).  
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One study (Nazareth et al., 2013) employed a four year quantitative longitudinal design. 
Quasi-experimental studies are frequently used when randomizing by location or subjects is 
difficult (Harris et al., 2006). Since randomisation was problematic because of smaller 
populations geographically dispersed (Nazareth et al., 2013), rationale was suitable. The study’s 
four year duration was a strength as it provided adequate time to identify trends. A TM-specific 
satisfaction survey was administered and all questions were reported within the study but the 
psychometric properties were not evaluated and it is not known if the survey had been previously 
validated.  
Similar to Ohl et al. (2013), the appropriate use of response to treatment indicators were 
used in Nazareth et al.’s (2013) study, however, the authors acknowledged two limitations: The 
study was not controlled and confounding factors were not analysed between the groups 
(Nazareth et al., 2013). Of note, while the sample size may have been sufficient, power analysis 
was not reported. These limitations made it difficult to know whether outcomes were due to the 
intervention (TM) or due to other differences between the groups. Therefore, this study was rated 
of low quality and results must be interpreted with caution.  
Quantitative pilot projects were utilized in three studies (Hassija & Gray, 2011; Hitt, 
Low, Bird, & Ott, 2013; Ross et al., 2016). Pilot studies are appropriate methods for the initial 
phase of determining the feasibility of delivering a specific healthcare service and play a key role 
in the development or refinement of new interventions (Leon, Davis, & Krawmer, 2010) such as 
TM.  
Hassija and Gray’s (2011) pilot study provided reasonably consistent results for a small 
sample size. Cohen’s d was used to calculate treatment effect size. The study used well-known 
reliable and valid data collection tools for patients with mental health disorders (DSM-IV 
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criteria, PTSD checklist, CES-D depression scale etc.), similar to Morland et al.’s (2015) RCT. 
Results were also consistent with the RCT (see Appendix E for further information). TM 
satisfaction was measured using the Wyoming Telehealth Trauma Clinic Satisfaction Scale that 
was specifically designed for the study (Hassija and Gray, 2011), but it is not known if this was 
validated.   
 Hassija and Gray (2011) failed to report on adequate power. The probability of obtaining 
adequate power with such a small sample size was low, and the findings would have been far 
more persuasive if the authors had reported the analysis and the limitations, such as what the 
probability was of finding real differences (power) and what were the changes from pre to post 
regardless of statistical significance (effect size). In light of these limitations, the study was 
downgraded to good quality.   
Hitt et al.’s (2013) study consisted of a large sample size and an adequate study duration 
of one year; however, adequate power was not reported nor was statistical analysis. Further, 
client satisfaction was based on a one question survey, thus this study was rated as low quality 
and results should be interpreted with caution. 
Ross et al.’s (2016) study consisted of an insufficient sample and no statistical analysis 
was reported, thus this study was rated low quality and results should be interpreted with caution. 
The study appeared to have used a TM-specific satisfaction survey, but sample questions and 
psychometric properties of the survey were not reported; therefore, it is unknown which survey 
was used (Ross et al., 2016). Feasibility results may not be necessarily generalizable but all three 
studies reported findings that can guide in the design and implementation of future studies. 
Holyk et al. (2017) used a quantitative survey that consisted of definitive conclusions 
based on good statistical analysis and an established p<0.05 as statistically significant (see 
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Appendix E for details). Power analysis was not reported and there was an increased risk of 
nonresponse bias; however, the surveys were clinician administered and might have had a higher 
response rate. Holyk et al. (2017) adapted their TM satisfaction survey from two previous TM 
studies (Field, 1996; Holden & Dew, 2008). Adaptations and psychometric properties were not 
reported. Although sample survey questions were not reported in the published article, an 
unpublished version of the article reported in-depth details on the questions used. Permission was 
granted to use the unpublished version in this review. For the remainder of this review, 
references made to Holyk et al.’s (2017) study will refer to the published version unless indicated 
otherwise.  A strength of Holyk et al.’s (2017) study was that the survey was informed by 
Browne et al.’s (2015) EQUIP-PHC study (providing equity-oriented care based on principals of 
harm reduction, cultural safety, and trauma and violence-informed care) which resonates with 
this population of interest in this review. Due to sampling bias and lack of validity in data 
collection methods this study was rated of good quality. 
This completes the quality appraisal of the evidence. Using the John Hopkins (2017) 
guide (Appendix F), Table 7 outlines the level and quality of evidence for each study. No study 
was excluded based on methodological grounds (Whittemore & Knafl, 2005). Whilst limitations 
were identified in the studies, these were not to an extent that warranted exclusion from the 
review. Overall, these studies help to answer the question this review seeks by contributing to a 
more in-depth understanding of the quality of evidence in TM research. As noted by Table 7, the 
level and quality of evidence varies across the studies.  
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Table 7. Evidence and Level of Quality Guide 
Author & Date Evidence Type Evidence Level & Quality 
Morland et al. (2010) 
Morland et al. (2015) 
RCT  
RCT 
Level I A 
Level I A 
Nazareth et al. (2013) Quasi-experimental Level II C 
Grindlay et al. (2013) 
Wyatt et al. (2013)  
Jhaveri et al. (2016) 
 
Qualitative (descriptive) 
Qualitative (descriptive) 
Qualitative (descriptive) 
Level III A 
Level III A 
Level III A 
Hassija & Gray (2011) 
 
Holyk et al. (2017) 
Quasi-experimental (pilot 
project)  
Quantitative (unpublished) 
Level III B 
Level III B 
Ohl et al. (2013) 
Ross et al. (2016) 
Hitt et al. (2013) 
 
Mixed-methods  
Quantitative (pilot project) 
Quantitative (pilot project) 
 
Level III C  
Level III C  
Level III C 
 
 
Further evaluation is needed to determine the meaning and relevance of the evidence to 
answer the first sub-question. At a glance, the evidence suggests that weak methodological 
quality may be a viable reason for poorer outcomes. Therefore, a critical analysis of the literature 
focusing on the four evidence-informed key elements of TM will be presented next. Following 
this will be a summary of the quality and quantity of the evidence.  
Key Elements of TM  
As previously discussed, four key elements of TM were identified in the literature (du 
Plessis et al., 2002; NIFTE, 2003; and Scott et al., 2007) and include: CPGs, clinical outcomes, 
rural settings, and human resources. These elements are considered foundational when 
comparing TM with face-to-face care for the topic of interest in this review. Table 8 outlines 
each element, indicator, and measurable outcome for TM that will be further evaluated in each of 
the relevant studies.  
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Table 8. Key Elements of TM. 
Element Outcome Indicator Measures  
CPGs Clinical Practice Guidelines 
 
Transparency reporting 
Current professional 
knowledge 
Clinical Outcomes Quality: Health status 
 
      
Acceptability: TM users 
 
Access: Utilization of services 
 
Response to treatment 
Patient reported outcomes 
 
Patient/provider satisfaction 
 
Timeliness, reduced travel, 
increased access 
 
Rural Settings Benchmark definition Transparency reporting 
Current professional 
knowledge 
Human Resources Mix of health care professionals 
 
Transparency reporting 
Current professional 
knowledge 
Source: du Plessis et al. (2002); NIFTE (2003); Scott et al. (2007). 
Therefore, the focus of this section is to provide a critical analysis of the relevant studies 
considering these four key elements in light of TM capacity to deliver care that is at least 
equivalent to the standard expected in traditional health care delivery.  
CPGs. According to the BC Health Care Charter (Ministry of Health, 2007), there is an 
expectation that TM needs to meet the same standards of care as face-to-face services; otherwise, 
as primary care providers we will fail to meet the standards of practice (CRNBC, 2017c). The 
purpose of clinical practice guidelines is to promote “best practice” and improve the delivery of 
health care services. The Institute of Medicine (2011) offers the following definition: “Clinical 
Practice Guidelines are statements  that include recommendations intended to optimize patient 
care that are informed by a systematic  review of evidence and an assessment of the benefit and 
harms of alternative care options” (p. 15). However, the challenge is whether existing CPGs can 
be safely applied to TM applications. NIFTE (2003) reported that depending on the TM 
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speciality and clinical application, modifications to CPGs may be required. Therefore, in the 
following Table 9, each study was evaluated for use of CPGs and any modifications that were 
required.  
Table 9. Clinical Practice Guidelines 
Clinical area 
 
CPGs Modifications 
Procedures Colposcopy1  
 
Training of RS providers in 
colposcopy; procedure is 
supervised by OBGYN at PS 
Ultrasound monitoring of at-
risk fetus2 
unknown 
Medication administration Chemotherapy3 
 
RS provider training; 
Blended services (first dose 
given at PS for safety); 
Procedure is supervised by 
PS 
HIV4 Unknown  
Hep C5 
 
Blended services; Detailed 
patient diary of adverse 
events; CPGs sent to RS 
providers; RC & patients 
aware of what to do if 
adverse events occur  
Medication assisted abortion6 Alternate consent form; 
medication was given using a 
remotely operated lock box 
Primary care General7 
 
Blended services 
Relationship-based care  
General8 
 
RS provided with a list of 
acceptable health conditions 
for TM visits 
Blended services 
Mental health9 First 1-2 sessions devoted to 
rapport building then 
treatment resumed 
Mental Health10 unknown 
Mental Health11 unknown 
1Hitt et al. (2013); 2Wyatt et al. (2013); 3Jhaveri et al. (2016); 4Ohl et al. (2013); 5Nazareth et al. (2013); 6Grindlay et 
al. (2013); 7Holyk et al. (2017); 8Ross et al. (2016); 9Hassija & Gray (2011); 10Morland et al. (2010); 11Morland et al. 
(2015). RS: receiving site; PS: providing site; FTF: face-to-face; blended services: combination of TM & FTF; 
**Information for CPGs and modifications are entirely reliant on the transparency of reporting, thus information 
was not available for all studies.  
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Specific CPGs were evident in nine studies (Grindlay et al., 2013; Hassija & Gray, 2011; 
Jhaveri et al., 2016; Morland et al., 2010, 2015; Nazareth et al., 2013; Ohl et al., 2013; Wyatt et 
al., 2013) and modifications to CPGs were reported  in seven of the 11 TM studies. Three studies 
(Grindlay et al., 2013; Jhaveri et al., 2016; Nazareth et al., 2013) were concerned with the safety 
of administering medications via TM. Modifications to CPGs in these studies included: 
administering the first medication dose (chemotherapy) at the providing site and if there were no 
adverse reactions, patients continued therapy in their local community with TM support (Jhaveri 
et al., 2016); the use of a remotely operated lock box, as a safety feature, to administer a 
witnessed medication dose for medically assisted abortion (Grindlay et al., 2013); and pathways 
outlining safety precautions of Hep C medications (e.g. patient diary recording adverse events, 
receiving site providers having access to the most recent CPGs, and clear instructions for 
emergency contacts in the case of an adverse reaction) (Nazareth et al., 2013).   
In two studies, (Hitt et al., 2013; Jhaveri et al., 2013), CPG modifications for colposcopy 
services and chemotherapy treatment, respectively, included additional training for rural 
providers so that the procedures could be offered in communities where patients would otherwise 
have to travel or not receive care at all. In one study, Ross et al. (2016) reported the use of 
specific criteria for screening patients at the receiving sites for conditions and symptoms deemed 
inappropriate for TM. A limitation of this strategy is that criteria originated at the providing site 
and was initiated at the receiving site with little input from rural providers. The implication here 
being that little consideration was given to the scope of practice or level of comfort for the 
individual rural providers.  
In four studies (Holyk et al., 2017; Jhaveri et al., 2016; Nazareth et al., 2013; Ross et al., 
2016), a blended model approach was utilized to assist and augment existing in-person services 
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with TM-based care. This suggests that routine face-to-face services may need to be modified for 
TM in order to provide effective and efficient care for rural patients. This is supported by two 
studies that were concerned with building trust with rural patients. Hassija and Gray (2011) 
modified the delivery of trauma-focused psychological treatment by allocating the first two TM 
sessions for rapport building prior to commencing therapy. Holyk et al. (2017) also was 
concerned with rapport, trust, and relationship building. Holyk et al.’s (2017) study focused on 
patient perceptions of culturally safe care. Table 10 lists the survey questions and patient 
responses (%). Survey questions were obtained from the unpublished version of Holyk et al.’s 
(2017) article.   
Table 10. Safe and Respectful Environments 
Welcomed by staff 87%  A/U Receptionist respectful  79.5    A/U 
Welcoming clinic space 88%  A/U HCP makes patient comfortable 95%    A/U 
Physically and emotionally 
safe 
91%  A/U HCP considerate of patient needs 95.5% A/U 
Treated with dignity and 
respect 
91%  A/U HCP comfortable discussing 
healthcare 
93%    A/U 
Discriminated by staff 86%  N HCP comfortable discussing 
anything 
95%    A/U 
Information adapted from: Holyk et al. (2017) unpublished version. A/U = Always/Usually; N = Never 
Overall, the results of the survey indicated that patients felt safe and were well-respected. 
Holyk et al. (2017) reported that although 86% of patients did not feel discriminated against, this 
also indicated that 14% of people felt that at some point staff had discriminated against them, 
suggesting an area for improvement. Holyk et al.’s (2017) study provided valuable data on the 
importance of addressing relationship-based care within TM services – specifically, with 
populations where structural inequities are at the root cause for poorer health outcomes.  
In two other studies that provided psychological treatment via TM (Morland et al. 2010; 
Morland et al., 2015) it was not clear if CPG modifications were warranted due to the exclusion 
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criteria (medication regime less than 45 days, substance use disorder and unwillingness to refrain 
during treatment and suicidal ideation). The degree of modification required for existing CPGs in 
cases like this is largely unknown when it comes to their use in delivering services via TM which 
implies that safety may be an issue. NIFTE (2003) reported the following about appropriate care 
via TM: 
The “appropriate” or “reasonable” standard of care (considering context, location and 
timing) delivered via telehealth should be at least equivalent to the standard expected in 
traditional health care delivery, where such a comparator exists. If the “reasonable” 
standard of care cannot be met, the telehealth professional needs to address what is the 
alternative for care and decide if it is acceptable to proceed (p. 33).  
Overall, these findings suggest that current standards of care were being applied in the 
studies. However, the problem is not with the application of best practice, it is about whether or 
not CPG modifications are needed for safe delivery of TM-based services. Only five of the 11 
studies specifically addressed the modifications required for the delivery of safe care via TM. 
While there is evidence of safe care being provided with modifications to CPGs in TM, a lack of 
reporting among the studies in this review precluded further analysis. The quality of evidence 
ranges from poor to high within the studies, thus the findings need to be interpreted with caution.  
As no comprehensive guidelines exist for managing the care of rural pregnant women 
with OUD (Jumah et al., 2015; SOGC, 2017b), safety of delivering treatment to this population 
will need to be considered. For example, complicating factors include the lack of dispensing 
pharmacies, OAT prescribers, and other support services within the local setting, which 
challenges access to medication as well as with ongoing health monitoring or dose adjustment 
issues. Thus, considering the context, location, and timing of providing care for pregnant women 
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with OUD, these findings suggest that the reasonable standard of care for face-to-face encounters 
may need to be modified for TM in order for primary care providers to deliver effective and 
efficient care.    
Clinical outcomes. Due to evidence-informed practice, interest in comprehensive 
evaluation of clinical outcomes is increasing (Scott et al., 2007). The literature on TM indicates 
that there is a lack of evaluation being applied in the area of clinical outcomes (NIFTE, 2003, 
Scott et al., 2007). Identification of appropriate indicators, their consistent description, and their 
consistent application in demonstrating comparable care to in-person services is lacking (Le 
Rouge, Garfield, & Hevner, 2015; Scott et al., 2007). For this review quality, access, and 
acceptability will be used to evaluate the clinical outcomes in the relevant studies.  
Quality. Quality of care refers to “the degree to which the health-care services for 
individuals and populations increased the likelihood of desired health outcomes and is consistent 
with current professional knowledge” (Scott et al., 2007, p. S2:6). The health status of patients is 
recognised as an evidenced-informed indicator of quality care that can be measured by the use of 
patient reported outcomes (PROs) or response to treatment disease-specific criteria. 
Three studies (Hassija and Gray, 2011; Morland et al., 2010; Morland et al., 2015) 
employed the use of PROs and two studies (Nazareth et al., 2013; Ohl et al., 2013) reported on 
response to treatment outcomes. Table 11 highlights the measurable outcomes for the five 
studies. There are limitations of comparing heterogeneous data. However, there are few 
opportunities in TM research to compare the same mode of delivery with similar health care 
services for rural populations where proximity to services is equivalent.  
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Table 11. Patient Reported Outcomes and Response to Treatment.  
Study  Measurable Outcome  Scores 
Morland et 
al. (2010) 
PROs 
Significant symptom 
reduction (complex mental 
health) 
TM FTF 
Baseline 56.7 (SD 
12.00) 
6m-posttreatment 
42.0 (SD 15.6)  
Baseline 55.0 (SD10.3) 
6m- posttreatment 46.6 
(SD 15.6) 
Morland et 
al. (2015) 
PROs 
Significant symptom 
reduction (complex mental 
health) 
TM FTF 
Baseline 67.6 (CI 
63.7-72.5) 
6m follow-up 46.5 
(CI 35.3-57.7)  
Baseline 67.3 (CI 62.5-
72.1) 
6m follow-up 52.3 (CI 
39.6-65.0) 
 
Hassija and 
Gray 
(2011) 
PROs 
Significant symptom 
reduction (complex mental 
health) 
One group TM 
Baseline 50.07 (SD 17.77) 
Posttreatment 32.20 (SD 12.68) Cohens d 1.17 
Baseline 27.47 (SD 14.12) 
Posttreatment 13.07 (SD 9.07) d 1.24 
Ohl et al. 
(2013) 
RTT 
Maintained undetectable 
viral loads  
Improvement in health 
screening 
(HIV – complex chronic 
disease management) 
One group TM  
Pre-TM Post TM 
N=15 100% viremia 
control 
 
N=23 95% viremia 
control 
Routine screening not 
done 
P=<0.05 improvement 
in screening measures 
Nazareth et 
al. (2013) 
RTT 
Maintained undetectable 
viral loads (Hep C – 
complex chronic disease 
management) 
TM FTF 
Sustained virological 
response >24w 
posttreatment = 72% 
(CI 95%) 
Sustained virological 
response >24w 
posttreatment = 68% (CI 
95%) 
PROs: patient reported outcome; RTT: response to treatment 
 
Three studies (Hassija and Gray, 2011; Morland et al., 2010; Morland et al., 2015) were 
concerned with demonstrating that TM-based care provided comparable outcomes to in-person 
services. The advantage of this is that TM becomes a supplement to existing services and not a 
replacement which may lead to buy-in of services for both patients and TM providers (Jennett et 
al., 2003). Hassija and Gray (2011), Morland et al. (2010; 2015),  demonstrated good to high 
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quality evidence that TM provided comparable care to face-to-face in the management of 
complex mental health. The PRO tools used in each study were appropriate for measuring mental 
health symptoms and were consistent with current professional practice (see Appendix E for 
more details). Further, the consistent application of PRO tools employed in the three studies 
(Hassija and Gray, 2011; Morland et al., 2010; Morland et al., 2015) helps to inform TM 
providers in a meaningful way that under these circumstances TM can produce similar outcomes.  
The remaining two studies (Ohl et al., 2013; Nazareth et al., 2013) involved chronic 
disease management of HIV and Hep C, respectively using response to treatment outcomes for 
maintaining undetectable viral loads. While measuring viral loads in response to treatment is 
consistent with current best practice and findings show that TM can provide comparable care 
(Nazareth et al., 2013; Ohl et al., 2013), methodological flaws limit these findings; thus, results 
need to be interpreted with caution. Further, if TM outcome indicators are to be useful, they must 
be chosen to specific criteria rather than in an ad hoc manner (Scott et al., 2007). This was 
reflected in comparing health screening measures between TM and face-to-face when in-fact 
screening was not part of usual care (Ohl et al., 2013). Another important consideration is that 
response to treatment measures are limited in terms of being surrogate endpoints, however, they 
are valid clinical measures that are currently in use and it is quite likely that for the population of 
interest in this review, future research will include similar surrogate endpoints. 
Overall, three studies of good to high quality (Hassija and Gray, 2011; Morland et al., 
2010; Morland et al., 2015) provided well-defined valid outcome measures that were able to 
inform providers, patients and organizations that the health status of patients could be maintained 
with the use of TM. However, due to poor quality and inconsistent application of outcome 
indicators in two studies (Nazareth et al., 2013; Ohl et al., 2013), it was not possible to draw 
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conclusions that patient health status could be maintained with TM. The implications of 
providing quality care via TM for pregnant women with OUD are far reaching: OAT has been 
shown to mitigate or reduce the medical, social, and legal consequences associated with OUD for 
both mother and fetus. Therefore, the appropriate identification and definition of valid outcome 
indicators for evaluating OAT in pregnancy via TM is needed, not only because of the 
substantive outcomes of relevance to patients but it also permits clear demonstration of value to 
policy and decision makers. 
Acceptability. Acceptability refers to “the degree to which patients, clinicians, or others 
are satisfied with a service or willingness to use it” (Scott et al., 2007, p. S2:6). Patient 
satisfaction is an important and commonly used indicator for measuring the acceptability of 
health care services, especially in TM (Scott et al, 2007; Whitten and Love, 2015). Only four of 
the eleven studies (Hassija and Gray, 2011; Holyk et al., 2016); Morland et al., 2015; Nazareth et 
al., 2013) employed TM-specific surveys. The benefit of this approach is that it helps to identify 
the aspects that are important and specific to a TM encounter such as patient perceived benefits 
and the quality of technology (Le Rouge et al., 2015). In the articles, the tools and measures were 
diverse but in all instances non-validated surveys were employed (Hassija and Gray, 2011; 
Holyk et al., 2017); Morland et al., 2015; Nazareth et al., 2013). Two studies (Hassija and Gray, 
2011; Nazareth et al., 2013) clearly stated what they were measuring in terms of satisfaction and 
provided sample questions and responses. Morland et al. (2015) and Holyk et al. (2017) 
identified the satisfaction tool employed but then did not provide clarity on the outcomes or 
provide sample questions. As previously noted, the unpublished version of Holyk et al. (2017) 
reported sample questions which provided a clear and concise outline of the tool that was used; 
thus, increasing generalizability and reproducibility of the results. Table 12 outlines the questions 
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from the four TM satisfaction scales and bolded items represent commonalities between the 
scales.  
Table 12. TM Satisfaction Scales. 
Morland et al. (2015) 
TM Satisfaction & 
Acceptability Scale 
(Frueh, Henderson & 
Myrick, 2005) 
 
Hassija and Gray 
(2011) 
Wyoming Telehealth 
Trauma Clinic 
Satisfaction Scale 
(Hassija & Gray)  
Holyk et al. (2017) 
Unpublished version 
 
Adapted from (Field, 
1996; Holden & Dew, 
2008)  
Nazareth et al. 
(2013) 
Psychometric 
properties not 
reported 
(1) sound quality 
(2) video quality 
(3) overall quality of 
communication 
 
(4) Confidence that you 
understood the 
interviewer’s questions  
 
(5) Confidence that the 
HCP understood you 
accurately 
 
(6) Overall confidence 
in the evaluation 
 
(7) Helpfulness of the 
service received 
 
(8) Overall quality of 
service  
 
(9) Satisfaction with the 
clinical encounter 
 
(10) Likelihood that 
you would use this 
service again 
if necessary 
 
(11) Recommend TM 
to others  
 
(1)sound quality 
 
(2) video quality 
 
(3) ease of equipment 
use 
 
(4) confidentiality of 
services 
 
(5) helpfulness of HCP 
 
(6) sensitivity of HCP 
 
(7) scheduling of 
sessions 
 
(8) timeliness of 1st 
appointment 
 
(9) matching of 
treatment to individual 
needs 
 
(10) respect shown to 
patient 
 
(11) overall quality of 
services 
 
(1) sound quality 
(2) video quality 
(3) clear 
communication 
 
(4) experienced 
technical difficulties 
 
(5) TM make exams 
difficult 
 
(6) Patient provided 
with enough TM 
information  
 
(7) reduction of out-
of-pocket expenses 
for transportation 
 
(8) recommend TM 
to others 
 
 
(1) sound quality 
 
(2) video quality 
 
(3) Privacy  
(4) nervous or 
uncomfortable 
with camera 
 
(5) overall 
satisfaction 
 
(6) confident of 
care received 
 
(7) TM reduced 
stress 
 
(8) saved time 
 
(9) saved money 
 
(10) recommend 
TM to others 
Bolded represents commonalities.  
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From a broad perspective, studies were concerned with measuring patient satisfaction 
with TM. This included: technical aspects such as sound and video quality; social aspects such as 
communication and provider helpfulness, respect, and sensitivity; privacy and confidentiality; 
and timeliness, convenience, and reduced travel. Each of the four studies (Hassija and Gray, 
2011; Holyk et al., 2017); Morland et al., 2015; Nazareth et al., 2013) emphasised technology, 
addressing specifically sound and video quality. 
While high levels of satisfaction were reported, the lack of consistency and validation of 
the surveys limits generalizability of the findings. In addition, the overall quality of TM 
satisfaction was often used as a general measure. For example, the question ‘were you satisfied 
with the overall communication?’ is inconsequential without first understanding what it is meant 
by communication. This could mean ‘was the communication clear?’ or ‘was the communication 
respectful?’ As a result, outcome measurements related to acceptability were open to 
interpretation. This view is upheld by Le Rouge et al. (2015), Scott et al. (2007), and Whitten 
and Love (2015) who each examined the satisfaction literature and concluded that many of the 
studies reporting TM satisfaction displayed methodological flaws related to poor design and data 
collection tools.  
Lack of consistency in satisfaction surveys also presents another problem. Two surveys 
(Morland et al., 2015; Nazareth et al., 2013) focused on technical aspects and failed to address 
professionalism of the encounter (e.g. cultural safety).  Patients may have been satisfied with the 
sound and video quality of the equipment but feeling cultural safety was not identified. If TM is 
not providing a culturally safe environment, then does it matter that the patient saved time and 
money due to less travel? This identifies that perhaps not all aspects of TM satisfaction should be 
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weighted equally. This view is well-supported by Holyk et al. (2017) who examined TM 
satisfaction through an equity-oriented lens.  
 Holyk et al.’s (2017) survey emphasized not only satisfaction as a broad outcome (as 
noted in Table 12) but also focused on more specific areas of satisfaction such as relationship-
based care. Holyk et al.’s (2017) survey measured levels of medical trust and attached verses 
unattached patients with in-person and TM services. Study results suggested that there was no 
statistically significant difference (p=0.26) with the use of TM on a patient’s level of medical 
trust verses patients who access only face-to-face visits (Holyk et al., 2017). The authors 
demonstrated evidence of a clear measurable outcome specific to TM care. 
Further, results in Holyk et al. (2017) reported statistically significant differences 
between patients accessing TM at their primary care home verses patients accessing TM on a 
walk-in basis. The results indicated that patients who accessed TM care with their primary care 
home were more likely to give a high rating of the service related to the following (Holyk et al., 
2017): satisfaction (p=0.01); effectiveness (p<0.001); convenience (p<0.001); usability 
(p=0.017). Of note, sample questions were not provided in the published article which limits TM 
programs from applying these findings in similar circumstances. Without first understanding 
what the user expectations were regarding satisfaction, effectiveness, convenience, and usability, 
results will not be able to guide future TM programs.   
Thus, while findings of patient satisfaction were extremely high in all four studies 
(Hassija and Gray, 2011; Holyk et al., 2017); Morland et al., 2015; Nazareth et al., 2013), greater 
than 90% on the majority of questions, results need to be interpreted with caution due to the lack 
of consistency within the surveys related to the technical and social aspects of TM satisfaction.  
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Access. Access refers to the “timely receipt of appropriate care, or the ease or difficulty 
in obtaining care, or the availability of the right care at the right time without undue burden” 
(Scott et al., 2007, p. S2:6). In this review 11 studies reported that TM improved access to 
services for populations in rural settings. The most commonly identified outcome indicators for 
measuring access fell under the auspices of time, travel, and distance (geographical barriers) 
which was perceived by patients that TM provided a more convenient service. This was 
supported by previous research outlining measurable indicators of access (NIFTE, 2002; Scott et 
al., 2007): 
1. Time – timeliness or time to access services; turn-around time or waiting time; lost time 
at work; travel time; or time spent away from home 
2. Travel and Distance – decreased travel or decreased distance; or decreased distance and a 
concomitant decrease in time. 
In the relevant studies, access was often addressed as other outcome indicators (e.g. time, travel, 
distance, and convenience were measured in satisfaction surveys). Although useful indicators of 
patient perceived benefits, this does not provide adequate evidence that TM improves access. 
Three studies (Grindlay et al., 2013; Hassija and Gray, 2011; Wyatt et al., 2013) reported TM 
provided more timely access to services but data on the precise times was not available. In one 
study (Grindlay et al., 2013) participants perceived TM prevented lost time from work but no 
actual times were recorded. In contrast, two studies provided a more detailed account of 
improved access via TM: Jhaveri et al. (2016) provided details of shorter wait times for TM 
visits (10-15 minutes) compared to one hour with a face-to-face visit; and in Ohl et al., 2013 
travel time was decreased by 150 minutes from 320 minutes per patient pre-TM to 170 minutes 
post-TM p<0.001. The number of patients that benefited from this was not reported in either 
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study. Overall, five studies (Holyk et al., 2017; Jhaveri et al., 2016; Nazareth et al. 2013; Ross et 
al., 2016; Wyatt et al., 2013) reported decreased travel based on varying degrees of distance from 
the providing and/or receiving sites as noted in Table 13. 
 In most cases, it is assumed that TM improves access by mitigating the geographical 
barriers associated with delivery of health care services for rural populations. Although this is 
most likely the case, the evidence in this review does not fully support this. Generic or vague 
descriptions of rurality prevent being able to precisely determine how access was improved. This 
is relevant in various rural contexts, including the proximity of communities to services where 
transportation is dependent on road conditions or by plane access only and for places like 
northern BC where inclement weather changes can pose serious threats to access regardless of 
transportation or distance (Ministry of Health, 2015). Therefore, identifying a common 
benchmark for understanding rurality is important; thus, du Plessis et al.’s (2002) Canadian 
benchmark rural and small town definition will be used to identity the degree of rurality in the 
relevant studies and will be presented next.   
Rural settings. In all 11 studies the idea of access was a common thread fundamental to 
quality, access, and acceptability of TM services. However, few of the studies were designed to 
sufficiently address the question of access and none provided a full definition of rural that 
included Canada’s rural and small town benchmark definition (du Plessis et al. 2002). Because 
the particular focus of interest in this review was on rural access to services, close attention was 
paid to how the researchers alerted readers to the depth and context of rurality. Within this 
category – distance, geographic proximity to services, and population data was identified. 
Accordingly, four descriptions of rural emerged: 1) not rural (Morland et al., 2010; Morland et 
al. 2015); 2) some attempt at defining distance (Grindlay et al., 2013; Hassija & Gray, 2011; Hitt 
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et al., 2013; Nazareth et al., 2013; Ohl et al., 2013); 3) proximity to services (Ross et al., 2016; 
Wyatt et al., 2013); and 4) proximity to services and population density (Jhaveri et al., 2016; 
Holyk et al., 2017). The results of this analysis are displayed in Table 13. 
Table 13. Rural Descriptions 
Not rural Some attempt 
(Distance)  
Proximity to services 
(Distance) 
Proximity to services 
& population size 
PS & RS located at 
same tertiary center1,2 
400mi round-trip3 
 
300-6430km round-
trip4 
 
A few hours away5 
 
Decreased travel time 
by 150min/year6 
 
Areas designated as 
rural7 
52-351km from PS & 
8-80km from RS8 
 
RS greater than 
280km from PS9 
 
 
RS 112, 202, 438km 
from PS with 
populations 4800, 
10,500 & 830010 
 
11 RS over 76,000 
sq. km with 
populations 100-
150011 
 
PS – Providing site; RS – Receiving site  
1 Morland et al. (2010); 2 Morland et al. (2015); 3 Grindlay et al. (2013); 4 Hassija & Gray (2011) 5 Nazareth et al. 
(2013); 6 Ohl et al. (2013); 7 Hitt et al. (2013);  8Wyatt et al. (2013); 9 Ross et al. (2016); 10 Jhaveri et al. (2016); 11 
Holyk et al. (2017) 
 
  Table 13 presents variable descriptions of the rural settings found in the relevant studies. 
Only one study (Jhaveri et al., 2016) provided enough information to resemble the rural 
benchmark (du Plessis et al., 2002); the proximity of services (from receiving site to providing 
site) was 112, 202, and 438km with population sizes of 4800, 10,500, and 8300, respectively 
(Jhaveri et al., 2016). While distance and population size are good starting points, the degree of 
integration communities have with larger urban centers is needed to fully understand “rurality” 
as it relates to individual communities (du Plessis et al., 2002). For example, there are several 
confounding factors associated with rurality, with the most common being availability of 
primary care providers and support services as well as the amount of travel time required to 
access services (e.g. road and weather conditions). 
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Holyk et al. (2017) and Ross et al. (2016) included detailed descriptions of the 
confounding factors affecting health care services in their respective communities: services were 
available to communities three to four days every six to eight weeks in Ross et al. (2016) and by 
flying in one day a month to provide primary care services in Holyk et al. (2017). However, it is 
important to note that primary care services are not only provided by physicians, despite a lack 
of reporting in the studies. Many rural areas in BC employ remote certified registered nurses that 
offer primary care services; which reinforces the lack of attention in research towards rural 
primary care, including nurses. Another example of a confounding factor that was not considered 
within a rural context was identified in Wyatt et al. (2013); it was discovered after 
implementation that support services for TM delivery included wider systems such as laboratory 
capabilities at the receiving site. A lack of knowledge about the availability of support services in 
varied rural communities led to disruptions in care. This enforces the importance of 
understanding the effects of rurality as it relates to the availability of health care services in each 
jurisdiction. As discussed earlier, only one study (Ohl et al., 2013) measured the degree of access 
to include the amount of travel time to access services. Therefore, it was not possible to conclude 
how efficient and effective TM was at improving rural access to services when rurality was not 
adequately defined as determined by Canada’s benchmark (du Plessis et al., 2002).   
Another important consideration for understanding rural settings other than by 
geographical classifications is equity of access (Browne et al., 2015; Scott et al., 2007). Although 
distance and equity are often related, equity of services involves a deeper understanding of the 
social inequalities that exist not only between rural and urban populations, but it acknowledges 
the differences among rural populations that affect access such as age, gender, financial status, 
ethnicity, and many others. Equity of access was addressed in Holyk et al.’s (2017) study where 
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maintaining medical trust between TM providers and those that have been negatively impacted 
by colonization was considered a high priority. The NTOIP agrees that equity of access must 
also be considered (Scott et al., 2007). This is verified in the literature where the majority of 
studies clearly indicated that many of the patients treated through TM would not have been able 
to access care due to their isolated geographical location and their vulnerable social 
representation (Hassija and Gray, 2011; Hitt et al., 2013; Holyk et al., 2017; Morland et al., 
2015; Nazareth et al., 2013; Ross et al., 2016). This is further emphasised in Hitt et al.’s (2013) 
study where 61% of women (out of 1,298) reported that without the TM program they would 
have waited for at least 12 months or not sought care at all. This group also made up 60% of the 
women with high-grade squamous lesion biopsies (Hitt et al., 2013). Pregnant women with OUD 
cannot and should not have to wait 12 months or longer or not seek care at all due to 
geographical proximity and uneven distribution of quality health care services.  
Overall, the findings suggest that access to health care services implies that some people 
have access while others do not. TM is a way of bridging this gap; however, none of the studies 
could adequately define rural to the degree that demonstrated TM improved rural access to 
services. Further, understanding the geographic proximity to services is important for the 
population of interest in this review given the prescribing, dispensing, and support services 
required to deliver OAT in rural communities. Therefore, this discussion will move forward to 
evaluate the last key element of TM care – human resources.  
Human resources. Human resources refers to the need of organizations providing TM 
services to have a “human resource plan to ensure the right supply and mix of appropriately 
trained staff, based on needs of the program” (NIFTE, 2003). This view is upheld by BC’s 
Health Charter (2007). Therefore, each study was evaluated for the health care provider 
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composition at both the receiving site and the providing site. Given the central focus of this 
review, it is imperative to identify the type and skill mix representative of the TM providers in 
order to ensure that they possess the necessary competencies for the safe provision of quality 
health services (CRNBC, 2015; NIFTE, 2003).   
In five of the 11 studies (Hitt et al., 2013; Jhaveri et al., 2016; Nazareth et al., 2013; Ohl 
et al., 2013; Ross et al., 2016) the type and mix of health care professional roles at both the 
providing and receiving sites were identified; all included health professionals from at least four 
disciplinary backgrounds – specialists, general practitioners (GPs), nurse practitioners (NPs), 
pharmacists, registered nurses, and licenced practical nurses; all of which represent an 
interprofessional collaborative approach (CRNBC, 2011). Although the above studies provided 
enough information to determine that an interprofessional collaborative approach to primary care 
services is appropriate for TM-based care, the majority of the studies were of poor quality; thus 
results must be interpreted with caution. The remaining six studies (Grindlay et al., 2013; Hassija 
& Gray, 2011; Holyk et al., 2017; Morland et al., 2010; Morland et al., 2015) lacked clarity on 
provider roles and included no data for the receiving sites. This suggests a considerable gap in 
the literature in regards to identification of rural providers and communication between rural and 
tertiary providers. The implications of this are far reaching, particularly if guidelines have to be 
altered, or for OUD in pregnancy, scope of practice may need to be considered. Thus, 
understanding and planning of appropriate human resources for TM programs aimed at 
delivering care to vulnerable populations living in rural communities is critical to providing 
accessible, quality safe care.   
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Summary of Quality and Quantity of Evidence 
Thus far, a quality appraisal of the relevant literature was conducted followed by a critical 
analysis of the four key elements known to affect TM care. Table 14 represents the findings 
associated with the quality and quantity of the evidence in light of TM capacity to deliver care 
that is at least equivalent to the standards expected in traditional health care delivery.   
Table 14. Quality and Quantity of Evidence 
Element Outcomes 
 
Quantity 
of 
Studies 
Quality 
of 
Evidence 
Findings 
CPGs Clinical Practice 
Guidelines 
9 3 poor 
1 good 
5 high 
Moderate evidence TM 
meets standards 
CPG modifications 6 3 poor 
1 good 
2 high 
Poor to moderate evidence 
TM meets standards 
Safety modifications 5 2 poor 
1 good 
2 high 
Poor to moderate evidence 
TM meets standards 
Clinical 
Outcomes 
Quality: Health status 
    Response to 
    treatment 
2 2 poor Weak evidence TM meets 
standards 
    PROs 3 1 good 
2 high 
Strong to moderate 
evidence TM meets 
standards 
Acceptability: TM 
satisfaction  
4 1 poor 
2 good 
1 high 
Weak evidence TM meets 
standards 
Access: Utilization of 
services 
2 1 poor 
1high 
Weak evidence TM meets 
standards 
Rural Settings Benchmark definition 0 N/A Weak evidence TM meets 
standards 
Human 
Resources 
Skill and mix of TM 
providers  
5 4 poor 
1 high 
Weak evidence TM meets 
standards 
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 As noted by Table 14, the quality and quantity of evidence was inconsistent across the 
studies when compared to CPGs, clinical outcomes, rural settings, and human resources. 
Findings show that three studies (Hassija and Gray, 2011; Morland et al., 2010; Morland et al., 
2015) provided enough evidence to demonstrate that TM can provide comparable outcomes to 
in-person care for improving the health status of patients with mental health disorders. Although 
moderate evidence was found for the use of appropriate CPGs, the modifications to ensure safe 
care did not meet the same standards. Where elements of TM care existed, methodological flaws 
and poor data collection methods contributed to weak evidence. The findings also revealed that 
the use of relevant outcome indicators was lacking despite existing TM guidelines. Further, no 
current benchmark exists for either rural settings or health care providers for the delivery of TM 
services.  All 11 studies did not specifically or sufficiently address the issue of access within a 
rural context. Overall, the studies analysed in this review did not provide enough quality 
evidence to support that TM meets the same standards of care as face-to-face. Therefore, it is 
difficult to identify whether TM can help meet needs of rural pregnant women in BC with OUD 
and to what extent TM could provide effective and efficient care in a rural context.  
Northern BC’s vast geography and dispersed populations introduces unique challenges 
that must be addressed with flexible and innovative ways of delivering health care services 
specific for rural populations (BC Ministry of Health, 2015). Currently, in BC there is a lack of 
guidance regarding a process for clearly defining a solid and consistent foundation to which all 
involved in TM can refer. This view is upheld by the studies in this review. To achieve a better 
understanding of the complex nature of TM, research may have to take a step back and return to 
the development stages.  The MRC’s (2006) framework for complex interventions states that in 
many cases, the development phase (identifying the evidence-base, identifying theory, and 
69 
 
  
modeling process and outcomes) has been bypassed in TM and researchers have launched into 
exploratory or pilot trials and RCTs, without sufficient preparation. This may, in part be a major 
contributing factor as to the methodological weaknesses in current TM research that is applicable 
in a rural BC context. Thus, returning to examine the requirements of the development phase, 
and assessing community readiness for TM services may be where TM research needs to be 
further evaluated. Therefore, the next section will analyse the level of TM readiness outlined in 
the studies included in this review.  
TM Readiness 
This section will begin with a critical analysis of the relevant studies to answer the 
second sub-question: Is community readiness (patient, provider, and organizational) an 
influencing factor for TM implementation? Before embarking on an initiative such as TM, there 
must be a reasonable probability that the intervention would be beneficial to service users, 
namely rural residents. Research has been focused on the benefits of TM (convenience, travel, 
and cost), which is often associated with high levels of patient satisfaction and promises of 
extending the reach of health care providers to improve access. In a recent systematic review on 
TM and patient satisfaction, Kruse et al. (2017) strongly advised that TM should not be without 
deliberate design and that attention is needed to safe-guard against the implementation of TM 
merely for its convenience. In repeated studies looking at TM implementation, readiness has 
shown to be a preliminary factor for success and sustainability (Jennett, Gagnon, & Bradford, 
2005; Information Technologies Group, 2002). Readiness for change “considers the capacity for 
making change and the extent to which individuals perceive the change as needed” (Jennett et 
al., 2005).  
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The purpose of this section is to examine and analyse the studies to identify the factors 
influencing patient, practitioner, and organizational readiness using Jennett et al.’s (2003) TM 
readiness framework (Appendix D). Five themes emerged from the literature that influenced the 
degree of TM readiness for patients, providers, and organizations: 1) desire for change; 2) TM 
awareness and education; 3) TM integration; 4) communication between domains; and 5) 
community consultation and needs assessment. These five themes will be discussed as they relate 
to Jennett et al.’s (2003) framework of core readiness, engagement, structural readiness, and non-
readiness. 
Core readiness. Core readiness refers to the “genuine need for telehealth services 
(usually based on conditions caused by isolation) and a felt or expressed dissatisfaction with 
services” (Jennett et al., 2003). The overarching theme emerging from the studies was the 
importance of choice for patients between modalities – TM or face-to-face. For patients, choice 
was important because it signals a desire for change and a willingness to help themselves 
(Jennett et al., 2003). Providing choice also puts patient-centered care at the forefront (Institute 
of Medicine, 2001). Six studies offered patients a choice between TM and face-to-face (Grindlay 
et al., 2013; Hitt et al., 2013; Holyk et al., 2017; Nazareth et al., 2013; Ohl et al., 2013; Ross et 
al., 2016).  
When given a choice, the majority of patients chose TM rather than face-to-face. In Ohl 
et al. (2013) 30 out of 32 patients chose TM with only two preferring to travel. In two studies 
(Grindlay et al., 2013; Nazareth et al., 2013) all participants chose TM. For three studies (Hitt et 
al., 2013; Holyk et al., 2017; Ross et al., 2016) the total number of participants that chose face-
to-face were not reported. However, nearly 1,300 participants in Hitt et al.’s (2013) study chose 
TM; it was not clear if the remaining 200 preferred face-to-face or were lost to follow-up or that 
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they did not require colposcopy services. For two other studies (Holyk et al., 2017; Ross et al., 
2016), permitting sufficient time for patients to become familiar with the modality may increase 
the likelihood of choosing TM services. Ross et al.’s (2016) study reported 280 TM visits were 
available and only 60 visits were utilized in the study’s short duration, however the number of 
visits did increase each month showing a growing interest in the modality. This trend was also 
reported in Holyk et al. (2017). Both studies (Holyk et al., 2017; Ross et al., 2016) supported in-
person visits with TM to provide care for at-risk Canadian populations.   
For patients, the most common reasons cited in the literature for choosing TM were 
convenience, less costs associated with travel, and faster access to care (Grindlay et al., 2013; 
Nazareth et al., 2013; Ohl et al., 2013; Wyatt et al., 2013). One interviewee reported feeling 
nervous about TM, but said it was more important for her to go to the closest clinic (Grindlay et 
al., 2013). Multiple participants in Ohl et al. (2013) reported that “travel burdens often made it 
difficult to obtain care . . .” (p. 1166). Likewise in Wyatt et al. (2013), interviewees emphasized 
“the process was faster” and there was “less money spent on gas” (p. 496). In Nazareth et al. 
(2013), a satisfaction survey revealed the majority of patients believed TM saved them money, 
time, and stress.  
For TM providers, core readiness was most notably recognized as “extreme 
dissatisfaction with the status quo” (Jennett et al., 2003). Isolation, disparate services, provider 
shortages, and inequitable access to services were contributing factors of readiness for health 
care professionals in eight studies (Grindlay et al., 2013; Hassija & Gray, 2011; Holyk et al., 
2017; Jhaveri et al., 2016; Nazareth et al., 2013; Ohl et al., 2013; Ross et al., 2016; Wyatt et al., 
2013). In Holyk et al. (2017) and Ross et al. (2016), health care providers were dissatisfied with 
the lack of primary care between in-person visits which caused many patients to travel for care. 
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Offering TM between visits was a way of providing continuity of care where the same providers 
could deliver care to their patients at a distance. (Holyk et al., 2017; Ross et al., 2016). Having a 
first-hand understanding of the negative effects of isolation is also an important consideration for 
TM provider core readiness (Jennett et al., 2003).    
 A significant finding in Ohl et al.’s (2013) study was that the need to address the 
problem of access was determined by both TM providers and patients during a needs assessment 
prior to TM implementation. In Jennett et al.’s (2002) earlier work, it was suggested that 
readiness and a willingness to try was just as important for providers as it was for patients. The 
lack of TM provider input from the rural receiving sites was a noticeable gap in the literature. In 
the only study to include the experiences of rural providers (Jhaveri et al., 2016), the expanded 
scope of practice associated with TM services was considered a benefit, however the six rural 
RNs expressed a need for more in-depth training. If rural users are not satisfied with the service 
or are unwilling to use it, the TM application will be unsustainable.  
Engagement. Engagement refers to a process in which people actively participate in the 
idea of TM, weighing the advantages and disadvantages (Jennett et al., 2003). This process was 
most obvious in patients, where they were aware of the negative effects of isolation, but lacked 
basic knowledge on how TM is expected to function. Since TM involves communication 
between multiple organizations, “a good working relationship between the providing and 
receiving sites is required” (Jennett et al., 2003, p. 29). In four studies (Grindlay et al., 2013; Ohl 
et al., 2013; Nazareth et al., 2013; Wyatt et al., 2013) a lack of TM preparation was an important 
factor contributing to a state of non-readiness for TM innovations. Many participants in Wyatt et 
al. (2013) reported having no TM preparation including that there would be cameras and 
multiple people in the room. One interviewee reported “it wasn’t just like one-on-one with the 
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doctor, I had two or three people watching me . . .” (Wyatt et al., 2013, p. 495). As a result of the 
study, changes to the TM program were implemented (Wyatt et al., 2013): Communication was 
improved between sites (receiving sites were better informed of the expectations of a TM visit) 
and patients were given an information package explaining exactly how TM was expected to 
function (Wyatt et al., 2013). This process of actively engaging patients in weighing the 
advantages and disadvantages of TM led to positive program changes and most likely increased 
readiness (Jennett et al., 2003). When patients become active participants in their health, they are 
more likely to have a sense of ownership and ownership promotes buy-in of services (Jennett et 
al., 2003). Of note, the TM program has been operational for more than 10 years which indicates 
that patient engagement is a fluid process that requires on-going assessment as new patients enter 
the program.  
Participants in Nazareth et al. (2013) experienced similar concerns of loss of privacy and 
the unexpected number of people during the encounter which indicated they were not well-
informed of the expectations of a TM visit. This was validated in two other studies (Ohl et al., 
2013; Ross et al., 2016) where there was a clear need to provide patients with reassurance that 
their privacy would be protected. Participants in Ohl et al. (2013) expressed interest in using the 
TM program provided that they felt secure that their privacy would be maintained. Likewise, in 
Ross et al. (2016) the authors reported that once providers prepared patients for a TM visit (e.g. 
explained equipment does not record, nor does the patient’s image get copied) patients became 
more open and talkative (Ross et al., 2016).   
The desire for privacy related to a sensitive health condition was a major concern for 
several participants in Grindlay et al. (2013). Participants reported choosing TM services because 
it provided anonymity from the anticipated stigma related to abortion. Being able to receive care 
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in their community (opposed to traveling) avoided having to explain their reasons for travel and 
time off work. However, during a TM visit one participant expressed privacy concerns and stated 
“. . . the nurse told me that it was just me and her [the doctor], that nobody else, its’s not 
broadcast or anything, so that made me feel like privacy was ok” (Grindlay et al., 2013, p. e120). 
Overall, the literature has demonstrated an increased need for TM awareness and education for 
patients prior to a TM visit, especially where privacy is concerned. Jennett et al. (2003) reported 
that a “genuine understanding of telehealth (understanding the various applications, their 
potential benefits and limitations) was linked to a readiness to adopt” (p. 261). On the other 
hand, a lack of understanding can lead to patients feeling more vulnerable, thus putting them at 
even greater risk of not receiving appropriate care.  
A lack of communication, particularly between health care professionals at the providing 
and receiving sites, also resulted in patients experiencing ambiguity about provider roles. In Ohl 
et al. (2013) patients described role confusion between providers at the different sites in regards 
to who should respond to more urgent health concerns. Despite having a TM framework 
outlining health care professional roles, this was still problematic which suggests that 
communication between organizations and providers also needs attention. Inter-group dynamics 
and cooperation between these groups was found to play a major role in readiness (Jennett et al., 
2003). However, 50 percent of the TM studies in this review did not identify the TM providers at 
the receiving sites, precluding further analyses of this group (Grindlay et al., 2013; Hassija and 
Gray, 2011; Holyk et al., 2017; Morland et al., 2010; Morland et al., 2015; Wyatt et al., 2013). 
These findings suggest that typically rural providers have not been involved with TM program 
development. This seems to be a significant gap in the literature.   
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On the other hand, the need for supportive and effective communication was highly 
recognised in four studies (Hassija and Gray, 2011; Holyk et al., 2017; Jhaveri et al., 2016; Ross 
et al., 2016). Building relationships based on trust and rapport with patients was a priority for 
TM providers in Hassija and Gray (2011), Holyk et al. (2017) and Ross et al. (2016).  This was 
accomplished by dedicating the first TM visit explaining expectations, security of the system, 
privacy and relationship building. Of note, all three studies included vulnerable populations 
(rural First Nations and domestic violence/rape victims) that may require a higher degree of trust; 
not unlike the population of interest in this review. The need for effective supportive 
communication was also emphasized in Jhaveri et al. (2016): Specialists commented on the 
“pivotal role” of tertiary nurses in the development of the model; rural nurses felt “adequately 
supported” by the providing site staff and described, “the communication has been excellent”; 
and tertiary nurses felt the specialists were “very approachable.” This was also the only study to 
include the views of providers at the TM receiving sites.  
Structural readiness. Structural readiness focuses on building adequate infrastructure 
(human resources, training, and technical) as a foundation for successful implementation 
(Jennett, et al., 2003). Structural readiness also includes ensuring TM services become integrated 
into existing services (Jennett et al., 2005). For seven out of the 11 studies (Grindlay et al., 2013; 
Hassija & Gray, 2011; Holyk et al., 2017; Jhaveri et al., 2016; Ohl et al., 2013; Ross et al., 2016; 
Wyatt et al., 2013) TM was built into existing health care systems. In all cases, the forming of 
partnerships with other agencies was fundamental for acquiring adequate facilities and 
equipment and to off-set the costs associated with implementation. As well, operations continued 
in each program after study completion with Hassija and Gray (2011) continuing on to a 
randomized control trial and Ross et al. (2016) expanding their pilot to two additional sites. In 
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three of the studies (Hitt et al., 2013; Morland et al., 2010; Morland et al., 2015) the TM program 
was created for study purposes and in all three cases operations ceased after study completion. It 
was clear that integrating TM into existing services provided a good foundation for program 
sustainability for the majority of the studies.  
Although implementing TM into existing services was clear, the organizational structure 
of the services was not. Five studies (Holyk et al., 2017; Jhaveri et al., 2016; Nazareth et al., 
2013; Ohl et al., 2013; Ross et al., 2016) described a blend of in-person and TM services. Two 
Canadian studies (Holyk et al., 2017; Ross et al., 2016) concluded that TM be a supplement to 
in-person services and not a replacement. Ross et al. (2016) reported that staff were more 
supportive once the project’s purpose was revealed in that, TM would “provide an adjunct to 
primary care, while not replacing in-person care” (p. 64). Likewise, in Holyk et al. (2017) TM 
was introduced to offer a blend of in-person visits supported by TM when the physicians were 
not in the community with the goal of determining “the desired effect of improving access to 
care without impacting the quality of care provided” (p. 17). This is to ensure that TM remains a 
quality supplement to in-person care rather than a replacement.    
Three other studies (Jhaveri et al., 2016; Nazareth et al., 2013; Ohl et al., 2013) described 
similar program elements that used a blend of in-person and TM services to support the needs of 
rural residents. Jhaveri et al.’s (2016) blended service model included one face-to-face visit (for 
the initial medication dose) followed by subsequent TM visits and Ohl et al.’s (2013) was a 
blend of TM and face-to-face for each visit; in both cases the blended model of care was 
designed in the planning stages prior to TM implementation based on the needs of patients and 
providers. However, Nazareth et al.’s (2013) study was unclear why patients needed a blend of 
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services but alluded to the expectation that future patients will seldom be required to travel, as 
the majority of care can occur via TM.  
One of the first steps in the successful implementation of TM services is planning. A well 
conducted needs assessment is a critical component of organizational readiness (Jennett et al., 
2003). Only two studies reported meeting this requirement (Jhaveri et al., 2016; Ohl et al., 2013) 
with sufficient details. A third study (Ross et al., 2016) reported that most (12 out of 14) TM 
providers felt they had enough input into the planning of the program and were interested in 
continuing with TM services, however the authors did not provide enough details on the extent 
of the needs assessment, thus conclusions could not be drawn. In contrast, Jhaveri et al. (2016) 
reported that a number of requirements were met prior to the development of a TM model of 
chemotherapy treatment. Structural readiness requirements included workforce, governance, 
training, information technology, selection of patients and treatment regimens, and 
documentation (Jhaveri et al., 2013). Ohl et al. (2013) was the only study in this review to obtain 
a thorough needs assessment prior to implementation of a TM model of care. TM program 
planning was initiated one year prior to implementation and included both provider and patient 
input towards the delivery of services. Patients were engaged in discussions on how TM would 
meet their needs and additional discussions with providers focussed on establishing necessary 
components of a TM framework that would meet the needs of their client population, including 
1) clear definition of roles for the primary care and speciality teams; 2) process to coordinate 
care across sites; and 3) systems to manage care across multiple sites (Ohl et al., 2013). Each 
component was accompanied by a thorough description.   
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Summary of TM Readiness 
 Findings from this review demonstrate several critical factors affecting TM readiness 
across all domains (patients, providers, and organizations): 1) desire for change; 2) TM 
awareness and education; 3) TM integration; 4) communication between domains; and 5) 
community consultation and needs assessment. Based on the relevant studies, Table 15 illustrates 
whether patients, providers, and organizations were ready or non-ready for TM innovations. 
Table 15. Factors Affecting TM Readiness  
Types of readiness 
 
Patient TM provider Organization 
Core readiness Recognition of unmet  
needs, sense of 
isolation 
Desire for change 
Willingness to try 
TM (ready) 
Dissatisfaction with 
the status quo  
Driving need to 
address the problem 
(ready) 
Recognition of 
unaddressed needs 
(ready) 
Engagement Awareness about the 
benefits/risks of TM 
(ready) 
Knowledge about 
what exactly TM is 
(non-ready) 
Communication 
between domains 
(non-ready) 
 
Established 
mechanisms of 
knowledge transfer 
between staff  
(non-ready) 
 
Structural readiness Education about TM,  
Sense of ownership, 
Awareness of TM; 
overcoming sense of 
vulnerability 
 (non-ready) 
Reliable education 
Addressing Rural 
provider concerns 
(workload, 
reimbursement) 
(non-ready) 
 
TM integration into 
existing systems 
(ready) 
Adequate 
facilities/equipment 
(ready) 
Assessing needs/ 
community 
consultation (non-
ready) 
Bolded indicates degree of readiness for TM 
As noted in Table 15, it is evident that all domains (patients, providers, and organizations) have a 
clear understanding of the negative effects of isolation. This understanding, in turn, promotes a 
desire for change and a willingness to try TM. However, it was also evident that patients, 
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providers, and organizations did not have adequate knowledge or education on TM which 
resulted in poor communication. In turn, poor communication contributed to an overwhelming 
sense of vulnerability in regards to patient privacy, as well as misconceptions of TM being 
implemented as a replacement to in-person services.  
In the majority of studies, structural readiness commonly occurred at the organizational 
level that included integration of TM into existing services and adequate facilities and 
equipment. However, instances of organizational non-readiness were evident by the lack of 
program planning prior to TM implementation. Without sufficient preparation (community 
consultation and a well-conducted needs assessment), the target population and their health care 
needs, how these needs can be met, and why TM is the most appropriate modality for meeting 
these needs, could not be fully understood (Jennett et al., 2003). Further, due to the lack of input 
from rural providers, important factors affecting readiness such as addressing workloads, 
reimbursement, and adequate education were not evaluated. Therefore, based on Jennett et al.’s 
(2003) framework, the majority of studies in this review did not appear to be completely ready or 
fully prepared for TM innovations.  
Overall Summary of Findings 
This review provided an opportunity to offer an integrative way to draw together various 
methodological studies on the use of TM. A critical analyses of the 11 papers found that while 
individual studies may have aspects of quality results, overall the findings demonstrate that TM, 
for the most part, lacks quality evidence to support its use. The findings from this review mirror 
those from recent systematic reviews (Ekeland et al., 2010; Flodgren et al., 2015; McLean et al., 
2011). There are several possible explanations for these findings. Firstly, poor methodological 
quality and data collection methods of the studies contributed to weak evidence as demonstrated 
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in Tables 7 and 14. In particular, valid, reliable, and measurable clinical standards and outcomes 
were poorly executed in the majority of the studies despite existing national and international 
TM guidelines.  
Secondly, and perhaps the most striking, the findings from this review demonstrate a lack 
of attention towards the development phase of designing, implementation, and evaluating TM 
applications. In only two of the studies reviewed, were considerations and findings guided and 
presented within a framework (Jhaveri et al., 2016; Ohl et al., 2013) and only one of those 
studies (Ohl et al., 2013) conducted a needs assessment that involved all stakeholders (providing 
and receiving sites, practitioners, and patients). The use of a framework, including a needs 
assessment, enables an approach that acknowledges the specific needs of patients and health care 
professionals. The magnitude of this challenge becomes more acute when we recognize the 
different levels of support required for individual rural communities – from larger communities 
that have primary care providers, laboratory, pharmacy, and other support service capabilities, to 
smaller more remote communities that are unable to sustain such services. In other words, TM is 
not a one size fits all approach. Rather, it requires some tailoring to meet the needs of the end 
users, most notably rural patients.  
Overall, the studies analyzed in this review did not provide enough quality evidence to 
determine whether TM can help meet the needs of rural pregnant women in BC with OUD and to 
what extent TM could provide effective and efficient care in a rural context. However, this does 
not necessarily mean that TM should not be used as a means to increase access to OAT services 
for rural pregnant women, rather the findings from this review indicate a further need to 
understand the fundamental elements of designing, implementing, and evaluating successful TM 
applications. This is significant because not only do NPs have the legislative authority to provide 
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interprofessional collaborative care for pregnant women with OUD, they also possess the 
knowledge of health care policy reform, community development, and health program planning 
that provides them with the tools to directly address vulnerable populations in BC that are 
systemically disadvantaged.   
Part of the graduate level of education for NPs includes the development of skills needed 
to research, critically appraise, and apply the literature related to clinical practice issues such as 
the delivery of health care services via TM. The NP is also expected to seek out opportunities to 
conduct or participate in research and to initiate the development of policy, practice guidelines, 
and standards of care (CRNBC, 2015). Therefore, potential strategies based on the findings from 
this review, to address how NPs can deliver TM-based care to pregnant women with OUD, will 
be discussed in the context of macro, meso, and micro-levels of health care systems followed by 
recommendations for practice. 
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Chapter Five 
Discussion 
The catalyst for this integrative literature review was the necessity to identify strategies 
for NPs and other primary care providers to address BC’s opioid crisis in the context of rural 
pregnant women. Specifically, this review focused on the capabilities of TM to deliver OAT 
services. While TM is generally viewed as an option to improve access to geographically 
dispersed communities, the link between the five key elements (CPGs, clinical outcomes, rural 
settings, human resources, and community readiness) have not been explicitly discussed and 
successfully implemented in the TM literature. In the context of macro, meso, and micro-levels 
of health care systems, NPs may be able to garner an improved understanding of these key 
elements and therefore provide the evidence needed to inform the use of TM applications for 
managing OUD in pregnant women living in rural BC.     
Macro, meso, and micro-levels refer to the policy level, the organizational and 
community level, and the patient interaction level, respectively (WHO, 2015). When these three 
levels “work effectively within themselves and successfully function in relation to each other, 
health care is efficient and effective; patients experience better health” (WHO, 2002, p. 31). Each 
of the findings of this review provided direction for making recommendations at the policy, 
organizational, and patient level of health care service delivery. Following the discussion, Table 
16 outlines key recommendations and suggestions for implementation are offered.   
Macro: System-Level – Health Care Policy  
 Contrary to expectations, this review did not find enough quality evidence to suggest that 
TM provides comparable services to in-person care. What is curious about this result is that all 
11 studies strongly reported otherwise. These differences can be explained in part by the 
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considerable quantity of data focused on “improving access” to support the successful 
implementation of TM. Although there appears to be general consensus in the literature relating 
to access, Scott et al. (2007) acknowledges that “. . . access means different things to different 
stakeholders in the health care system” (p. S2:10). For example, see the article by Levesque, 
Harris, and Russell (2013) for a summary of the different conceptualizations of access. It may be 
that participants in the relevant studies benefitted from improved access to services; however, 
none of the studies could adequately demonstrate these results. This indicates that no formal 
structured process was used to examine outcome indicators that would be appropriate for 
evaluating TM services which implies issues at the policy level.  
 Health systems and technical innovations are rapidly developing and changing. A key 
macro factor impacting on the uptake of TM has been the lack of consistent policy between the 
health professions on TM. Identifying the direction TM guidelines and standards should take is 
the responsibility of the regulatory bodies to ensure policy reflects the nature of the intervention. 
This is reflected not only in the varied definitions of TM (Appendix C) but it also includes the 
different modes of delivery, the users, the providers, the location, and the context of the TM 
interaction. Without consensus at the policy level, health services are likely to be wasteful and 
fragmented (WHO, 2002) as shown by the lack of evidence for measurable outcomes in TM 
found in this review.  
The recent interprofessional collaborative efforts of the three regulatory bodies in BC 
(CRNBC, CPSBC, and CPBC) have responded to the opioid crisis by working together to ensure 
that changes to NP Scope of Practice align with the prescribing/dispensing practices for OAT 
that are held to the same standards of care required of physician and pharmacist colleagues 
(CRNBC, 2017a). This collaborative move, along with the creation of the BCCSU (2017), has 
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created a window of opportunity for policy change regarding TM. NPs have the opportunity to 
influence the formation of TM health policy to better reflect the delivery of health care services 
in rural BC.  Through the literature analysis, the following recommendations at the macro level 
include:  
• Together, the three regulatory bodies, CRNBC, CPSBC, and CPBC will build a unified 
TM policy that addresses TM in the context of primary care and rural settings. 
• CRNBC, CPSBC, and CPBC will determine a broad set of guidelines for individuals          
and organizations to use a benchmark for TM service provision (e.g. NIFTE and NTOIP).  
• Establish TM as part of the education curriculum for physicians, NPs, and pharmacists. 
At the macro level taking action towards disseminating the findings of this review would 
offer an opportunity to communicate and interact with wider policy and health service 
audiences. Presenting the findings of this review at the BCNPA annual conference is one 
way that may facilitate the knowledge of TM innovations in BC.  
Meso: Organizational-Level – Structure of Services   
The meso-level is where policy begins to take shape as a specific program (WHO, 2015) 
such as delivery of OAT services for rural pregnant women in BC. It is at this level where the 
policy gets negotiated into a program with specific scope and deliverables. This review identified 
limited evidence of a clear process guiding the design, implementation, and evaluation of TM 
programs. The findings of this review identify a significant gap in the literature regarding the 
limitations of translating current research into clinical practice. This indicates a need to further 
understand the various elements associated with TM: CPGs, clinical outcomes, rural settings, 
human resources, and community readiness. 
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Clinical standards and outcomes “. . . must be chosen according to agreed criteria rather 
than in the prevailing ad hoc manner” (Scott et al., 2007, p. S2:2). This view is strongly upheld 
by two Canadian TM reports (NIFTE, 2003; Scott et al., 2007). Standardization of practice relies 
on guidelines that inform decision-making towards optimal provision of services while also 
making clear their appropriate use in a given context (WHO, 2015). Responding to this 
challenge, primary care providers have the opportunity to bring about the necessary changes to 
practice by advocating for use of evidence-informed standards and outcomes in the context of 
TM program development. There was strong evidence from this review to support the need for 
CPG modifications to help ensure safe delivery of medications via TM (Jhaveri et al., 2016; 
Nazareth et al., 2013; Wyatt et al., 2013). This is an important finding given the safety concerns 
of the medications involved for the treatment of OUD in pregnancy.  
However, research to date has not been able to provide robust evidence that TM provides 
similar outcomes to in-person services. These results are likely related to the inconsistent use of 
outcome indicators measuring the quality, access, and acceptability of TM services. These results 
mirror those of the previous studies that have examined outcomes in TM research (Le Rouge et 
al., 2015; NIFTE, 2003; Scott et al., 2007). In considering the specific needs of vulnerable 
populations including pregnant women with OUD, this has significant implications towards 
providing effective, efficient, and equitable health care service delivery. 
Rural settings and human resources are two other elements important to the development 
of TM programs in northern BC. TM has been repeatedly described in the literature as a 
modality for improving access to health care services for rural and remote communities 
(Romanow, 2002; Scott et al., 2007; WHO, 2010). As the number of TM projects, programs, and 
services has steadily increased in recent years, minimal attention is being placed on rural 
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communities. A challenge in selecting and analyzing the studies included in the review was 
defining what it means to be rural. Indeed, no accepted definition of rural emerges in the TM 
literature. This includes knowledge of geographic proximity to services, local supports and 
services, the skill and mix of health care professionals, and the unique barriers individual 
communities are facing. The fact that no studies in this review adequately define rural supports 
this. This list of issues demonstrates the need to revisit and reassess the components within 
which TM operates, namely rural communities. For northern BC, TM programs must be 
designed, implemented, and evaluated within a rural context that includes the voices of rural 
residents and rural providers.  
Community readiness is a vital element of TM program development and arguably the 
most important. Assessment of both community and provider readiness for TM were found to be 
essential components of a needs assessment (Jennett et al., 2003). Provider and patient readiness 
necessitates looking at factors including: the community’s needs; epidemiological data; the 
community’s health care resources; the skill and mix of health care providers in the community; 
what is realistic access to services; and what is feasible (Jennett et al., 2003). All of which 
support the importance of determining the level of rurality for the individual community. 
Interestingly, only one study (Ohl et al., 2013) reported consulting the community and 
performing a needs assessment prior to program implementation. The findings of this review 
suggest that it is possible that the development stages of TM have been bypassed and researchers 
have launched into implementation and evaluation without sufficient preparation (Craig et al., 
2006). This also suggests that a lack of community readiness along with poor change 
management are responsible for TM not being adopted at the expected rate. Although only 
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speculative at this time, change management theory may play a more active role within TM and 
thus deserves further consideration in the future of TM research.  
Overall, these findings suggest that there are five key elements of a TM program that 
need to be addressed at the meso-level to ensure adequate design, implementation, and 
evaluation of TM programs: CPGs, clinical outcomes, rural settings, human resources, and 
community readiness. The following recommendation is guided by the findings in this review 
and has been applied in the context of delivering OAT services for rural pregnant women via 
TM: 
• Establishment of an interprofessional collaborative committee to oversee the 
development of a TM framework and guidelines specific to the management of OAT in 
rural pregnant women: Perinatal Services BC, SOGC, Midwifery, NPs, GPs, rural 
providers, and pharmacy. Focus is on translating current policy towards a workable 
program. This includes: CPGs, clinical outcomes, rural settings, human resources, and 
community readiness. 
At the meso level, individual NPs might consider taking action by contacting the BCCSU to 
discuss how current OUD guidelines might be adapted for TM service delivery in rural 
communities. 
Micro: Clinical-Level – Provision of Clinical Services  
 The micro-level is the integration of policy and guidelines into every-day clinical practice 
where patients and providers interact in a meaningful way that influences health care outcomes. 
Two common problems at the micro-level are “the failure to empower patients to improve health 
outcomes and the lack of emphasis on quality interactions with health care personal” (WHO, 
2002, p. 31). TM encounters challenge the traditional face-to-face mode of health care delivery. 
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For vulnerable populations this challenge has the potential to further limit access to care rather 
than draw people in. The findings from this review suggest that building trust and rapport and 
maintaining privacy between patients and providers is key to successful TM interactions. 
However, building relationships and ensuring quality communication in TM encounters between 
providers and patients remains poorly understood. This was reflected by the fact that many 
patients lacked a basic understanding of what TM was and how it was expected to function 
which highlights the issue of whether patients truly gave informed consent. In order for patients 
and providers to have meaningful interactions the balance of power needs to shift towards 
patients so that they can actively participate and take ownership of their health care needs. 
Therefore, until TM becomes “routine practice” it should follow suit with other medical 
interventions and informed consent should be fully obtained prior to delivery of the service 
(Maheu, Whitten, & Allen, 2001).   
 The findings of this review also suggest that a blend of in-person visits supported by TM 
not only addresses patient safety but it fosters the building of relationships between patients and 
providers. Tailoring OAT services to meet the needs of vulnerable women, such as offering 
choices and easing into health care encounters are high impact ways of recognizing people’s 
vulnerability and moving towards building trust and rapport (Browne et al., 2012) as essential 
components of TM. This view was upheld by Hassija and Gray (2011), Holyk et al. (2017), and 
Ross et al. (2016) where permitting sufficient time for patients to become familiar with the 
modality led to improved access and more meaningful interactions based on trust. Perhaps the 
most striking finding is the equity-orientated approach in Holyk et al.’s (2017) study that 
addressed the structural inequities of BC’s rural populations through the use of TM. Although 
this was the only study to provide evidence that TM was capable of delivering culturally safe 
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services to vulnerable populations, it is arguably the most important finding in this review. This 
indicates a substantial need to understand the link between health inequities, primary care, and 
TM in the context of northern BC populations.  
Following a correspondence with a leading scholar in the field of TM in BC, Dr. John 
Pawlovich, a family physician and co-author of the Holyk et al. (2017) study, he strongly 
believes that TM is designed to be a complementary tool that extends the reach of primary care 
providers. He states, “The foundation of technology is to support longitudinal care – but it is not 
the end game” (personal communication, November 19, 2017). Dr. Pawlovich moves on to 
explain that relationship-based care plays a pivotal role in the provision of health care services 
for populations that have historically been disadvantaged; thus, providers must continue to 
intentionally foster trusting relationships while providing care at a distance (personal 
communication, November 19, 2017). The findings from this review have the potential to build 
on the recent work of Holyk, Pawlovich, Ross, and Hooper (2017) to include an equity-oriented 
approach to health care service delivery via TM.  
  The following recommendations are guided by the findings in this review and represent 
the key components associated with offering TM-based services that are tailored to empower 
patients at the micro-level of health care service delivery: 
• TM providers create and maintain culturally safe environments with an emphasis on 
equity-oriented care that fosters quality health care interactions between providers and 
patients. 
• Follow all ethical and legal requirements that relate to patient decision-making and obtain 
informed consent. 
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At the micro level individual NPs might consider taking action by developing evidenced-
based informed consents and TM satisfaction surveys that consider the historical, cultural, 
and geographical influences that have affected Indigenous populations in northern BC. This 
would include consulting individual rural communities for their valuable input as informed 
and respected stakeholders. 
The following Table 16 includes key recommendations for the design, implementation, and 
evaluation of TM programs at the macro, meso, and micro-level of health care service delivery. 
With each recommendation suggestions for implementation are offered.    
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Table 16. Key Recommendations for TM Design, Implementation, and Evaluation.  
Health Care 
System 
Level 
Recommendations Suggestions for Implementation 
Macro 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Together, the three regulatory bodies, 
CRNBC, CPSBC, and CPBC will build 
a unified TM policy that addresses TM 
in the context of primary care and rural 
settings. 
 
 
 
• TM definition: 
 CPSBC (2015) definition 
 To ensure a primary care focus, this review suggests 
videoconferencing be the primary mode of delivery in TM 
applications designed for increasing access to services 
 TM is a complimentary tool not a replacement, therefore 
each patient has the choice to decline participation  
• Rural setting definition: 
 To ensure the optimal use of TM services in BC, PCPs 
who use TM have knowledge about the level of rurality in 
the community where they are providing the service (e.g. 
geographical proximity to services, availability of health 
care providers and support services in the community). 
This review suggests du Plessis et al.’s (2002) benchmark 
definition. 
• Equity-oriented provision of services: 
 Follow all ethical and legal requirements to providing 
culturally relevant care that includes building relationships 
and eliminating existing inequities.  
• TM providers have a professional responsibility to provide 
robust evaluation of services that include monitoring quality 
and outcomes of TM applications to improve services for 
patients and providers 
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Health Care 
System 
Level 
Recommendations Suggestions for Implementation 
 
 
Macro 
2. CRNBC, CPSBC, and CPBC will 
determine a broad set of guidelines for 
individuals and organizations to use as 
a benchmark for TM service provision 
to which all involved with TM can refer  
 
• The following guidelines and frameworks are suggested to be 
used as a point of reference towards the development of more 
specific TM programs:  
 National Initiative for Telehealth Framework of 
Guidelines (NIFTE, 2003) 
 National Telehealth Outcome Indicators Project NTOIP 
(Scott et al., 2007) 
 Jennett et al.’s (2003) framework for investigating the 
readiness of rural and remote communities for TM 
 
3. Establish TM as part of the education 
curriculum for physicians, NPs, and 
pharmacists. 
 
 
• Education on TM policy as indicated above with a focus on 
interprofessional collaboration and patient education. 
• TM demonstrations 
• Practicums to include TM-based care 
Meso 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Establishment of an interprofessional 
collaborative committee to oversee the 
development of TM guidelines specific 
to the management of OAT for pregnant 
women in a rural context 
 
• Committee members to include: 
 SOGC 
 Perinatal Services BC 
 Midwifery 
 NPs 
 Obstetricians, GPs, rural providers, social work, and 
pharmacy 
 Indigenous community representation 
• Focus is on translating current policy towards a workable 
program in a rural context. This includes: 
 CPGs 
 Clinical outcomes 
 Rural settings 
 Human resources  
 Community readiness. 
93 
 
  
Health Care 
System 
Level 
Recommendations Suggestions for Implementation 
Meso 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Clinical Practice Guidelines: 
Prescribing professionals will use 
current existing CPGs for OAT in 
pregnant women to guide the delivery 
of care in the TM setting, recognizing 
that modifications may need to be made 
to accommodate specific circumstances 
(e.g. prescribing, dispensing, and 
support services) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• The following evidence-informed resources can be considered 
in the management of pregnant women requiring OAT: 
 The management of opioid use dependence during 
pregnancy in rural and remote settings (Jumah, Graves & 
Khan, 2015) 
 No. 349-Substance use in pregnancy SOGC Clinical 
Practice Guideline (SOGC, 2017) 
 Screening and management of substance use in 
pregnancy: A review (SOGC, 2017) 
 Epidemiology and effects of substance use in pregnancy 
(SOGC, 2017) 
 A guideline for the clinical management of opioid use 
disorder (British Columbia Center on Substance Use, 
2017) 
• CPG modifications – Prescribing  
OUD treatment involves narcotics, therefore safe prescribing 
practices in a rural context need to be established. In order to provide 
OAT via TM, PCPs are advised that they are responsible to: 
 not prescribe narcotics to patients whom they have not 
personally examined or with whom they do not have a 
longitudinal relationship 
 ensure patients meet the criteria for SUD as per DSM-V 
 ensure patients meet the criteria for OAT 
 ensure both the providing site and receiving site 
communicate and determine follow-up care, roles and 
responsibilities of each provider and after-hours care as 
medically appropriate 
 communicate with providers on managing adverse events 
and who to contact in an emergency 
• CPG modifications – Dispensing 
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Health Care 
System 
Level 
Recommendations Suggestions for Implementation 
Meso 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CPGs continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dispensing practices will vary between communities depending on 
the level of services. PCPs are responsible for the following: 
 To ensure availability of dispensing services or 
appropriate alternatives prior to OAT. This includes 
knowing who will dispense and/or witness doses 
 Determine appropriate protocols for carry privileges in 
rural and remote areas. This includes availability of safe 
medication storage (e.g. using a remote lock box) and 
consideration of the current barriers to obtaining carries 
(e.g. the difficulties of meeting the 12 week requirement 
of single dose administration in communities that do not 
have secure dispensing services). 
 
• CPG modifications – Support services 
Support services (laboratory, pharmacy, mental health and 
counselling, social work services, and providers) will be dependent 
on the level of services. PCPs are responsible for the following: 
 Identifying the support services in each community and 
appropriate alternatives where no services exist. This 
includes identifying the skill and mix of health care 
professionals. 
 Follow all ethical and legal requirements to providing 
culturally relevant care that includes building relationships 
and eliminating existing inequities  
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Health Care 
System 
Level 
Recommendations Suggestions for Implementation 
Meso 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Clinical Outcomes: Organizations will 
assist health care providers in the 
collection, evaluation, and reporting of 
health care outcome data for TM. 
Evidence-informed indicators 
measuring clinical effectiveness and 
efficiency of TM services will include: 
Quality, access, acceptability 
 
• Quality: 
 Employ the use of validated tools to evaluate quality 
 Ensure appropriate quality indicators (PROs, RTT, 
morbidity, and mortality)    
• Access: 
 Assessing patient perceptions of access (barriers to care) 
 Assessing time: timeliness or time to access services; turn-
around time or waiting time; lost time at work; travel time; 
or time spent away from home 
 Assessing travel and distance: decreased travel or 
decreased distance; or decreased distance and a 
concomitant decrease in time 
• Acceptability: 
 Employ the use of valid and reliable tools to evaluate 
satisfaction of TM services for patients and PCPs and to 
include patient perceptions of: cultural safety, trust, 
respect 
4. Rural Settings: Du Plessis et al.’s 
(2002) benchmark rural definition (rural 
and small town) will be used to evaluate 
the rural settings of patients requiring 
OAT treatment.  
• OAT providers will be responsible for identifying: 
 Geographical proximity to services 
 Population data 
 Local community resources and support services  
 Knowledge of transportation options 
 Rural health care providers 
5. Human Resources: Consideration of a 
human resource plan to reflect the 
complex aspects of TM and OAT 
services.  
• Organizations will assist with identifying the right supply and 
mix of appropriately trained health care professionals at each 
site (providing and receiving) based on patient need. 
 Interprofessional teams may include: Obstetricians, 
specialists in addictions, NPs with perinatal experience, 
GPs, RNs, pharmacy, laboratory, mental 
health/counselling, and social work 
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Health Care 
System 
Level 
Recommendations Suggestions for Implementation 
• Providers are responsible for identifying the support services 
in each community and appropriate alternatives where no 
services exist. 
 
6. Readiness: TM providers will consider 
community (patient, provider, 
organization, rural setting) readiness 
prior to TM implementation. 
• Organizations will ensure that the environment is “ready” for 
TM prior to implementation and put strategies in place to 
assist with identifying patient, provider, and organizational 
readiness based on a needs analysis using Jennett et al.’s 
(2003) TM readiness framework. This will include a focus on 
community consultation and rural provider involvement. 
 
Micro 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. TM providers create and maintain 
culturally safe environments with an 
emphasis on equity-oriented care that 
fosters quality health care interactions 
between providers and patients. 
 
• TM providers can consider implementing the following 
measures to foster equity-oriented care as demonstrated in 
Holyk et al.’s (2017) study: 
 Ensure a welcoming clinic space that includes community 
input 
 Incorporate a blended model approach of in-person 
services supported by TM encounters. 
 Ensure TM clinic rooms protect and maintain patient 
privacy 
 Ensure video equipment is well-positioned to promote 
appropriate eye contact between the provider and patient. 
 Provide opportunities for community engagement prior to 
TM implementation (e.g. TM encounter demonstrations 
and education). 
 Address barriers to care including social determinants of 
health 
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Health Care 
System 
Level 
Recommendations Suggestions for Implementation 
 
 
 
 
 
 
Micro 
2. Follow all ethical and legal 
requirements that relate to patient 
decision-making and obtain informed 
consent. 
 
• Patients have a right to the following information: 
 who is participating in the encounter 
 how a TM encounter will work 
 potential risks and benefits 
 the choice to decline and available alternatives 
 contingency plans should the equipment fail during an 
encounter 
 how security, privacy, and confidentiality will be 
maintained 
 who is responsible for on-going care 
 what to do in an emergency 
 the right to withdraw consent at any time 
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Limitations and Future Directions 
 A major limitation to this integrated literature review is the external validity of its 
findings to pregnant women with OUD in northern BC. To date, no studies have been conducted 
that specifically address this population in the context of TM and rurality. While the findings of 
this review have also been discussed in the context of primary care services in northern BC, 
direct recommendations for rural pregnant women with OUD cannot be made solely upon this 
research. Only two of the 11 studies in this review included Indigenous populations, which are 
widely represented in northern BC. Although no attempt was made to include/exclude 
participants of ethno-cultural backgrounds due to the scarcity of research on the topic of interest, 
this review acknowledges that the findings must also be considered in the context of the 
historical, cultural, and geographic influences that have occurred with Indigenous populations in 
northern BC. Thus, all recommendations presented in this review should be guided and 
implemented with the knowledge and expertise of Indigenous peoples of northern British 
Columbia. 
 Another limitation to this review is the lack of attention towards funding models that 
support interprofessional collaborative efforts that are required for TM applications. In 
particular, funding models that are more responsive to working with fee-for-service (FFS) 
primary care providers. For example, groups of existing FFS primary care providers could apply 
directly through the NP funding process to add an NP to their team to improve primary care 
access. Thus, the NP would become an employee of the entity requesting the funding. This is 
currently being proposed by the British Columbia Nurse Practitioner Association (BCNPA) as a 
new model to integrate NPs into primary care (BCNPA, 2016); an area that will require further 
attention by the health authorities in BC if TM is to be sustainable. 
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Further research conducting quantitative and qualitative studies is required. Higher 
quality quantitative research such as quasi-experimental designs would help to identify positive 
and negative outcomes of OAT via TM; thus, making it an ideal method given BC’s geography 
(limited availability of sample sizes with multiple dispersed rural locations). Qualitative research 
is needed to examine those outcomes and to explore rural pregnant women’s experiences 
following OAT via TM. It is also important to focus on how TM was perceived by the staff who 
experienced it, namely rural providers. 
Although only briefly identified in this review, change management theory may play a 
significant role in the adoption of new innovations such as TM. With current political discourse 
emphasizing a need for change in the delivery of health care services for rural populations, 
researchers must look to provide quality evidence for best approaches to successfully achieve 
change. The lack of a robust body of literature to assess the applicability of change management 
models in TM presents an excellent opportunity for further research.  
Lastly, findings from this review have the potential to move beyond pregnant women 
with OUD to include a broad range of reproductive health issues affecting rural women in BC, 
such as: obesity, cervical cancer screening, colposcopy services, mental health, SUD (alcohol, 
tobacco, marijuana, and other substances), and the myriad other health issues that 
disproportionately affect rural populations. TM holds incredible potential for decreasing the 
barriers associated with geography, and as such, all health care providers have the opportunity to 
unite their expertise to include their full scope of practice. This too, presents excellent 
opportunities for further research into the reproductive health issues facing vulnerable 
populations and team-based models of care in the context of TM applications in BC.     
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Conclusion 
 Primary care providers in BC have an opportunity to assist in guiding policy and planning 
in TM innovations. Delivering care to rural pregnant women is a major concern for primary care 
providers because of the medical, social, and legal consequences of OUD for mother and fetus. 
Increased mortality and morbidity for the dyad is severe. Effective evidence-informed treatment 
for OUD in pregnancy includes methadone and buprenorphine; however, further consideration 
for prescribers, dispensing pharmacies, and locally available supports in rural communities is 
needed. TM has the ability to overcome these geographic barriers and help deliver OAT services 
to BC’s most vulnerable populations. However, this integrated review illustrates issues of quality 
research in TM. A better understanding of TM approaches and resultant outcomes in quality, 
access, and acceptability are needed.  
 Key elements of TM that contribute to effective and efficient health care delivery service 
include: CPGs, clinical outcomes, rural settings, human resources, and community readiness. As 
health care organizations continue to invest in TM, it is important to pay specific attention to 
community readiness. Gaining a greater understanding in TM readiness is an important first step 
in the successful design, implementation, and evaluation of such complex innovations as TM.  
  It appears TM is a promising health care modality. However, more work needs to be 
done to ensure TM provides effective and efficient health care services. New research must 
consider the context, location, and timing of how TM is being implemented, in a way that is 
conceptualized to uphold the principles and priorities of delivering care to pregnant women with 
OUD in northern BC. This includes consideration of how TM translates from a policy level to a 
workable program level and in turn, implemented locally.  
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 Lastly, the findings of this review have the potential to build on the work of Holyk, 
Pawlovich, Ross, and Hooper’s (2017) equity-oriented approach to TM-based care and provide a 
key direction going forward.  This will ensure the successful transition of a new primary care 
innovation such as TM into real clinical practice in the context of rural pregnant women with 
OUD in northern BC. To conclude, a quote by Muriel Strode is offered: 
Do not follow where the path may lead.  
Go instead where there is no path and leave a trail. 
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Appendix A  
DSM-5 Criteria for Opioid Use Disorder 
 
 
 
1 Opioids are often taken in larger amounts or over a longer period than was intended  
The presence 
of at least 2 of 
these symptoms 
indicates an 
Opioid Use 
Disorder (OUD) 
The severity 
of the OUD is 
defined as: 
MILD: The 
presence of 2 to 
3 symptoms 
MODERATE: 
The presence of 
4 to 5 symptoms 
SEVERE: The 
presence of 6 or 
more symptoms 
2 There is a persistent desire or unsuccessful efforts to cut down or control opioid use 
3 A great deal of time is spent in activities necessary to obtain the opioid, use the opioid, or 
recover from its effects 
4 Craving or a strong desire to use opioids 
5 Recurrent opioid use resulting in a failure to fulfill major role obligations at work, school, or 
home 
6 Continued opioid use despite having persistent or recurrent social or interpersonal problems 
caused or exacerbated by the effects of opioids 
7 Important social, occupational, or recreational activities are given up or reduced 
because of opioid use 
8 Recurrent opioid use in situations in which it is physically hazardous 
9 Continued use despite knowledge of having a persistent or recurrent physical or 
psychological problem that is likely to have been caused or exacerbated by opioids. 
10 Tolerance, as defined by either of the following: a) Need for markedly increased amounts of opioids to achieve intoxication or 
desired effect b) Markedly diminished effect with continued use of the same amount of opioid 
11 Withdrawal, as manifested by either of the following: a) Characteristic opioid withdrawal syndrome b) Same (or a closely related) substance is taken to relieve or avoid withdrawal 
symptoms 
Source: American Psychiatric Association (2013) 
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Appendix B 
Opioid Substitution Treatment by Health Authority, BC 2012/2013 
Patients, Active Prescribers, Pharmacists, Pharmacies 
 
Health 
Authority 
Patient Active 
Prescriber 
Pharmacists Pharmacies 
Northern 
 
430 21 189 45 
Fraser 
 
6,716 76 1,188 279 
Vancouver 
 
4,722 173 906 197 
Victoria 
 
2,787 61 564 137 
Interior 
 
2,338 29 563 146 
BC Total 
 
15,754 344 2,886 804 
Source: Office of the Provincial Health Officer (2014) 
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Appendix C 
TM Definitions 
Organization Definition 
World Health Organization (WHO, 2010) “Telemedicine is the delivery of health care 
services, where distance is a critical factor, by 
all health care professionals using information 
and communication technologies for the 
exchange of valid information for diagnosis, 
treatment and prevention of disease and 
injuries, research and evaluation, and for the 
continuing education of health care providers, 
all in the interests of advancing the health of 
individuals and their communities” (p. 9). 
 
Institute of Medicine (1996) “Telemedicine is the use of electronic 
information and communications technologies 
to provide and support health care when 
distance separates participants” (p. 1) 
 
The College of Physicians and Surgeons of 
BC (CPSBC, 2015) 
“Telemedicine is the provision of medical 
expertise for the purpose of diagnosis and 
patient care by means of telecommunications 
and information technology where the patient 
and the provider are separated by distance. 
Telemedicine may include, but is not limited 
to, the provision of pathology, medical 
imaging and patient consultative services” (p. 
1). 
College of Registered Nurse of BC 
(CRNBC, 2017) 
“Telehealth refers to the use of 
communications and information technology 
to deliver health and health care services and 
information over large and small distances” 
(p. 1). 
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Appendix D 
Rural Readiness for Telehealth Model 
Type of 
readiness 
 
Public Patient         Practitioner Organization 
Core Readiness 
 
 
 
 
 
 
 
 
 
Engagement  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structural 
Readiness 
Dissatisfaction with the current 
state of  health-care 
Dissatisfaction with typical 
doctor–patient interaction; desire 
for  a more comfortable  setting  
for obtaining health  
information; 
Desire for  change Isolation;  
poor access 
 
 
Wanting to know what 
telehealth  is; having a clear 
definition  of telehealth 
Recognizing (or estimating) the 
benefits of telehealth 
Having a  sensitive  health 
condition;  desire  for  privacy 
regarding  health practice 
 
 
 
 
 
 
 
 
 
 
 
 
Education/Availability of  formal  
Sense of isolation, lack of access 
Recognition of unmet  need Desire 
for  change; willingness actively  
to  help  themselves or their 
condition 
 
 
 
 
 
 
Knowledge  about what  exactly 
telehealth is 
Knowledge  about the  benefits (or  
anticipated benefits) 
Fear of damaging equipment 
Gender 
Privacy  concerns Availability  
and reliability of content that fits  
rural or remote culture 
Address concerns  about Sense  of 
ownership 
telehealth  as a  replacement for  
existing services 
 
 
 
 
 
 
 
Education about  telehealth 
Extreme dissatisfaction with the 
status quo 
First-hand understanding or 
experience of negative effects  
of  isolation 
Driving need  to  address a 
public  or  patient problem (as 
opposed  to a practitioner -
specific  one) 
 
 
Innovators; champions Sense  of 
curiosity 
Peer  influence Evidence of 
utility 
Inter-group  cooperation 
(between  practitioners  and the  
other domains) 
Intra-group  cooperation  
(between  working practitioners) 
Communication 
Openness; respect  for  others 
Willingness  to make initial 
extra  investment  in time 
 
 
 
 
 
 
Addressing  scheduling  
concerns;  overextended 
Recognition of unaddressed  
needs; Dissatisfaction  with  the 
organizational status quo 
 
 
 
 
 
 
 
 
Champions 
Availability of risk takers, 
pioneers Education and 
awareness for innovators 
Reduction of nay-sayers 
/resisters; Ability/willingness of 
senior administration to 
consider  benefits outside  
standard business  case/cost- 
effectiveness schemes; 
Willingness  to consider  long  
timelines for implementation; 
Movement  from  short-term  
funding; short-term  
accountability deadlines 
Cost–benefit analysis 
Established mechanisms  of  
knowledge transfer  between 
staff 
 
Identification  of  equipment  
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Type of 
readiness 
 
Public Patient         Practitioner Organization 
 
 
and informal  information 
networks 
Availability  of  testimonials 
from people 
Awareness  campaigns  
Champions,  especially local 
ones 
Community  consultation 
sessions;  sense  of ownership 
Healthy  inter-organizational  
dynamics  in  promotion activity 
 
 
Awareness  of telehealth; 
overcoming  sense  of 
vulnerability  in videoconference 
Ability  or  training to  use 
equipment 
Practitioner-mediated  liaison for  
telehealth programmes 
 
 
workloads 
24-hour  access  to  equipment 
Established reimbursement 
plans 
Reliability  of  equipment;  good 
technical  support;  backup 
plans 
Confirmation  of  reliable  and 
available  clinical consultants 
Reliable content (clinical and 
continuing medical education) 
Liability 
 
 
difficulties; ‘bugs’ 
Well  conducted  needs  
assessment Community  
consultation process; 
ownership 
Allowance  for creative use of 
equipment by practitioners  and  
patients 
Accessible,  comprehensive  
technical support,  locally  
available  and on-call 
Effective scheduling; integration 
into the  routine 
Proper  facilities  (lighting,  size,  
heating); adequate equipment 
Accessible,  sustained  staff 
training (including  training at 
medical  school to encourage   
routine   perception) 
Provision  of a telehealth  
coordinator Written  policy on 
reimbursement, 
liability,  cross-jurisdiction  use,  
privacy  Sufficient  ongoing  
funding (local, 
provincial, federal)  
 
Source: Adapted from: Jennett et al. (2003). 
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Appendix E 
Literature Review Matrix 
Article / Study 
Design / & Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer 
research question 
Morland et al., 2010 
Hawaii, U.S. 
 
Non-inferiority RCT. 
 
Comparing outcomes 
of anger management 
therapy via TM with 
FTF care  
 
 
 
 
Randomized  
125 male 
veterans w PTSD 
61 Intervention 
64 Control  
Adequate 
Randomization 
(similar 
demographic 
variables for both 
groups  
 
 
Adequate power 
86%-97% 
 
 
Veteran  
satisfaction survey 
(validated) 
 
patient reported 
scales (validated) 
CAPS; Trait anger 
scale; PTSD 
checklist 
 
DSM-IV criteria 
 
Scores compared at 
baseline, mid-
treatment, 
posttreatment and 3 
& 6 months 
posttreatment 
 
Adequate power to 
detect inferiority 
 
Statistical analysis 
consistent with non-
inferiority trials 
PS & RS at the same 
tertiary site 
 
HCPs – limited data, 
qualified mental 
health therapist 
providing care 
 
12 evidenced-based 
CBT sessions with 2 
sessions per week 
for 6 weeks 
Not rural 
 
Lacked clarity of 
HCP roles between 
PS & RS 
 
Program created for 
study/services 
ceased after 
completion 
 
 
 
 
 
 
 
 
 
 
 
TM meets same 
standards of            
care as FTF 
 
Valid and reliable 
data collection tools 
 
Evidenced-based 
care: psychotherapy 
 
High risk 
populations 
 
+ response to 
treatment (↓ 
symptoms) 
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Appendix E 
Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Participants 
 
Data collection  
method 
Setting 
HCPs at the  
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings 
that help answer 
research question 
Morland et al. (2015) 
Hawaii, U.S. 
 
Non-inferiority RCT  
 
Comparing outcomes 
for PTSD treatment 
via TM verses FTF 
care  
 
  
Randomized  
126 female 
civilian & 
veteran w PTSD 
Adequate 
Randomization 
(similar 
demographic 
variables for 
both groups  
 
mean age 46; 
Caucasian 47%, 
ethnic 53%; 46% 
have current 
comorbid 
psychiatric 
conditions 
(depression/anxi
ety, substance 
use)adequate 
power 0.90 
Veteran satisfaction 
survey (validated) 
 
TM specific 
satisfaction scale 
(psychometric 
properties not 
reported) 
 
Mental health 
patient reported 
scales (validated) 
CAPS 
 
DSM-IV criteria 
 
Scores compared at 
baseline, mid-
treatment, 2 weeks 
posttreatment, and 
3 & 6 months 
posttreatment 
 
 
PS & RS at the same 
tertiary site – no 
other data provided 
 
HCPs – limited data, 
qualified mental 
health therapist 
providing care 
 
12, 90 min 
evidenced-based 
sessions with 1-2 
sessions per week 
 
 
 
 
 
Not rural 
 
Program created for 
study/services 
ceased after 
completion 
 
Lacked clarity of 
HCP roles between 
PS & RS 
 
 
TM meets same 
standards of            
care as FTF 
 
Valid and reliable 
data collection tools 
 
Evidenced-based 
care: psychotherapy 
 
High risk 
populations 
 
+ response to 
treatment (↓ 
symptoms) 
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Appendix E 
Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Sample/Sample size 
 
Data Collection  
 
Setting 
Providing site 
(PS)  
Receiving Site 
(RS 
Limitations Study findings 
that help answer 
research question 
Grindlay et al. (2013) 
U.S. 
 
Descriptive qualitative 
study 
Participant experiences 
(HCPs and women) of 
providing medical 
abortion services via 
TM 
n=25 pregnant women 
(majority 18-24 y/o) 
 
n=15 HCPs (GPs, RNs, 
medical assistants, 
clinic managers)  
 
Convenience sampling 
 
 
Consistent with 
method; Semi-
structured 
interviews 
(digitally 
recorded, 
transcribed 
verbatim) 
 
Inductive thematic 
coding 
 
 
 
 
 
 
 
 
PS – tertiary clinic 
GP 
 
RS – unknown  
 
 
 
Rurality not well-
defined 
 
Lacked clarity of 
HCP roles 
between PS & RS 
 
 
In-depth patient & 
HCP perspectives 
 
High-
risk/pregnancy 
population 
 
Evidenced-based: 
medications 
 
Operational 
program since 
2008 
 
TM integration 
into existing 
services 
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Appendix E 
Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer 
research question 
Wyatt et al. (2013) 
U.S. 
 
Qualitative descriptive 
study  
 
Women’s experiences 
of receiving a poor 
pregnancy prognosis 
via TM 
 
 
n=8 pregnant 
women (mean 
age 30y/o) 
 
purposeful 
 
 
  
Consistent with 
method; Semi-
structured 
interviews (digitally 
recorded, 
transcribed 
verbatim) 
 
Iterative thematic 
coding  
 
 
 
 
 
PS – specialist & 
other HCPs tertiary 
clinic 
 
RS – nurses, GP, 
U/S technician  
 
Distance lived from 
PS (mean 226km) 
 
Distance lived from 
TM clinic (mean 
33km)  
 
 
 
 
Rurality not fully 
defines 
 
Lacked clarity of 
HCP roles between 
PS & RS 
 
 
In-depth patient 
experiences 
 
high risk/pregnancy 
population 
 
operational  
program since 2002 
 
Evidenced-based 
care: primary care 
 
Study resulted in 
program 
improvements 
 
TM integration into 
existing services 
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Appendix E  
Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer research 
question 
Jhaveri et al. (2016) 
Australia 
 
Descriptive  
qualitative study  
HCP perspectives of 
providing 
chemotherapy 
services for rural 
populations via TM 
 
  
Purposeful 
sample 
n= 19 HCPs 
 
specialists, GPs, 
RNs, pharmacist 
 
  
Consistent with 
method 
 
Semi-structured 
interviews 
(digitally recorded, 
transcribed 
verbatim) 
 
Iterative  thematic 
coding 
 
Triangulation 
 
 
 
 
 
 
PS – specialist, 
pharmacist & RNs 
tertiary clinic 
 
RS – GPs, RNs. 
pharmacist at 3 rural 
satellite sites  112, 
202, 438 km from 
PS with populations 
4800, 10,500, 8300 
 
 
 
 
 
 
 
 
 
 
 
no data on 
patient 
acceptability  
 
In-depth HCP 
experiences, including 
RS HCPs 
 
Evidenced-based care: 
medication  
 
HCP type and mix 
identified at RS & PS 
 
TM integration into 
existing services 
 
Interprofessional 
collaboration 
 
TM framework used 
 
Blended services (1 FTF  
supported by TM visits)  
  
high risk populations 
 
TM safety addressed  
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Appendix E 
Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer 
research question 
Ohl et al. (2013) 
U.S. 
 
Mixed-methods  
3 year study  
Evaluated the use of  
TM for providing HIV 
care  
 
 
 
96% male 
Veteran (median 
age 54) 
 
Quantitative 
n=30 (n=17 
pre/post period; 
n=24 start of 
treatment/post) 
N=5 new patients 
half way through 
 
Non-random 
Convenience 
 
qualitative n=13  
 
 
 
 
 
Quantitative: one-
group pre/post-test 
Paired t-
test/McNemar  
 
satisfaction survey 
(validated for 
veteran use) 
 
 
Qualitative: semi-
structured   
interviews (digitally 
recorded, 
transcribed 
verbatim) 
 
Iterative thematic 
saturation 
 
 
 
 
 
 
 
PS – specialist, 
pharmacist & nurses 
at a tertiary center 
 
RS: 7 rural TM sites 
with GPs/NPs 
 
Operating one half 
day/week 
 
 
 
Rurality not well-
defined 
 
Threats to internal/ 
external validity 
 
Power analyses not 
obtained 
 
TM specific 
instruments not 
used 
 
 
 
 
 
 
Evidenced-based: 
medication & 
primary care 
 
Interprofessional 
collaboration 
 
HCP type and mix 
at RS & PS 
 
TM framework  
 
+ response to 
treatment outcomes 
 
30/32 chose TM  
due to convenience, 
cost, travel 
medical home 
model 
 
High-risk 
populations 
 
TM integration into 
existing services 
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Appendix E  
Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer 
research question 
Nazareth et al. (2013) 
Australia 
 
4 year Longitudinal 
quasi-experimental  
Comparative study 
 
Compared TM to FTF 
Hep C treatment 
responses  
 
Sample method 
unclear 
(convenience 
/purposeful) 
 
TM n=50 (50% 
female, mean age 
46) 
convenience 
 
FTF n=559 (35% 
female, mean age 
43) comparison 
group  
 
 
Pre/post-test  
Clopper-Pearson 
95% CI 
 
TM satisfaction 
survey  
(psychometric 
properties not 
reported) 
 
 
 
PS – specialists, 
NPs, pharmacist 
tertiary hospital 
 
RS – GPs nurses  
 
 
 
 
 
 
 
 
 
Rurality not well-
defined 
 
 
Blended services 
(FTF & TM) not 
well-defined  
 
Threats to internal 
validity 
 
Lacked adequate 
power 
 
Confounding factors 
not analysed   
 
 
 
Study method 
 
TM specific 
satisfaction survey 
(+ responses) 
 
Evidenced-based: 
medications 
 
TM safety 
 
High-risk 
populations 
 
HCP type and mix 
RS & PS 
 
Interprofessional 
collaboration 
 
+ response to 
treatment 
 
50/50 chose TM for 
convenience, cost, 
travel 
124 
 
  
Appendix E 
Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer 
research question 
Hassija & Gray 
(2011) 
U.S. 
 
Quantitative pilot 
project  
 
Evaluated TM-based 
treatment for women 
experiencing domestic 
violence and sexual 
assault  
 
 
 
 
Sample method 
unclear 
(convenience 
/purposeful)  
 
n=15 women 
(mean 30 y/o)   
 
No comparison 
group 
 
 
TM specific 
satisfaction scale  
psychometric 
properties not 
reported 
 
Mental health 
patient reported 
scales (validated) 
PTSD checklist 
CES-D depression 
scale 
 
DSM-IV criteria 
 
Pre/post-test design 
Cohen’s d (effect 
size)  
 
 
 
PS – mental health 
therapist tertiary 
clinic 
 
RS – 3 TM 
rape/crisis centers 
several hours away 
from PS, HCPs not 
reported 
 
Weekly sessions 
 
Rurality not well-
defined 
 
Lacked clarity of 
HCP roles between 
PS & RS 
 
Threats to internal 
validity 
Study method 
TM specific 
satisfaction survey 
(+ responses) 
 
Evidenced-based 
care: mental health 
& PC 
 
High risk 
populations 
 
Response to 
treatment (↓ 
symptoms)  
 
TM implemented 
into existing 
services 
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Literature Review Matrix Cont. 
Article / Study 
Design / & Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer 
research question 
Hitt et al. (2013) 
U.S. 
 
Quantitative 1 year 
pilot project  
  
Evaluated colposcopy 
screening for rural 
women via TM 
 
 
Sample method 
unclear 
(convenience 
/purposeful) 
 
n= 1,298 women 
(mean age 25)  
 
No comparison 
group  
 
One-question  
satisfaction survey 
(psychometric 
properties not 
reported) 
 
Analyses not 
reported 
 
 
PS – specialist 
tertiary center 
 
RS – NPs in 4 rural 
satellite sites 
 
Services 3hrs 
weekly 
 
 
 
Rurality not well-
defined 
 
Lacked clarity of 
HCP roles between 
PS & RS 
 
Program ceased 
after study 
 
Weak analyses 
 
 
Study method 
 
High risk 
population 
 
Evidenced-based: 
PC 
 
Interprofessional 
collaboration  
 
HCP type and mix 
RS & PS 
 
1298 women chose 
TM 
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Literature Review Matrix Cont. 
Article / Study 
Design / & 
Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer research 
question 
Ross et al. (2016) 
AB, Canada 
 
3 month pilot project  
Evaluated access to 
primary care services 
via TM for 2 rural 
First Nations 
communities  
 
 
Sample method 
unclear 
(convenience 
/purposeful) 
 
 Sample size  
unclear (72% 
female; majority 
age 19-36 
 
 
HCP-administered 
satisfaction survey 
(psychometric 
properties not 
reported) 
 
Number of visits, 
reasons for care, 
age 
 
Methods not 
defined 
 
 
 
 
 
 
 
 
 PS – GP, NPs, RNs 
primary care clinic 
 
RS – LPNs in 2 
rural communities 
over 280km away 
from PS 
 
3 afternoons per 
week 
Rurality not well-
defined 
 
Weak statistical 
analyses 
 
Threats to internal/ 
external validity 
 
Short study 
duration 
 
 
Study method 
 
Evidenced-based care 
primary care   
 
Interprofessional 
collaboration  
 
HCP type and mix 
identified at RS & PS 
 
TM implemented into 
existing services 
 
Adjunct to primary 
care, not replacing in-
person care 
 
Blended model (FTF & 
TM) 
 
TM safety addressed 
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Literature Review 
Matrix Cont. Article 
/ Study Design / & 
Overview 
Sample/Sample 
size 
 
Data Collection  
 
Setting 
Providing site (PS)  
Receiving Site (RS 
Limitations Study findings that 
help answer 
research question 
Holyk et al.  (2016) 
British Columbia 
 
Quantitative pilot 
project  
 
Examined primary 
care services via TM 
for rural communities  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample method 
unclear 
(convenience 
/purposeful) 
 
n=210 64% 
female 
Mean age 47  
 
No comparisons 
Adapted TM 
satisfaction survey 
Not validated 
 
Adapted survey 
questions EQUIP 
Not validated 
 
Independent t-test  
  
(one-way ANOVA 
Welch) 
 
P-value = <0.05 
 
 
 
 
 
PS – limited data 
reported, GP 
 
RS – HCPs not 
reported 11 rural 
sites  
(76,000 sq km) 
populations of 100-
1500  
 
 
Rurality not well-
defined 
 
Lacked clarity of 
HCP roles between 
PS & RS 
 
Unpublished 
 
Non-response bias 
 
Study method 
TM specific 
satisfaction survey 
(+ responses) 
 
Evidenced-based 
care: primary care 
 
TM safety 
safe/respectful 
environment 
 
High risk 
populations 
 
High level of trust 
with TM 
Blended services 
3:1 FTF/TM visits 
 
Primary care home 
TM integrated into 
existing services  
(Program running 
since 2011)  
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Appendix F 
Johns Hopkins Nursing Evidenced-Based Practice 
Evidence Level and Quality Guide 
 
Evidence Levels 
 
Quality Guides 
Level I  
Experimental study, randomized controlled trial (RCT) 
Systematic review of RCTs, with or without meta-analysis  
A High quality: Consistent, generalizable results; sufficient sample size for the 
study design; adequate control; definitive conclusions; consistent 
recommendations based on comprehensive literature review that includes 
thorough reference to scientific evidence 
 
B Good quality: Reasonably consistent results; sufficient sample size for the 
study design; some control, fairly definitive conclusions; reasonably consistent 
recommendations based on fairly comprehensive literature review that includes 
some reference to scientific evidence 
 
C Low quality or major flaws: Little evidence with inconsistent results; 
insufficient sample size for the study design; conclusions cannot be drawn 
Level II  
Quasi-experimental study 
Systematic review of a combination of RCTs and quasi-
experimental, or quasi-experimental studies only, with or 
without meta-analysis 
 
Level III  
Non-experimental study 
Systematic review of a combination of RCTs, quasi-
experimental and non-experimental studies, or non-
experimental studies only, with or without meta-analysis 
Qualitative study or systematic review with or without a 
meta-synthesis 
 
 
 
© The Johns Hopkins Hospital/Johns Hopkins University.  May not be used or reprinted without permission. 
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Appendix F cont. 
Directions for Use of This Form 
Purpose: This form is used to compile the results of the evidence appraisal to answer the EBP question. The pertinent findings for 
each level of evidence are synthesized, and a quality rating is assigned to each level.  
 
Total Number of Sources per Level: Record the number of sources of evidence for each level.  
 
Overall Quality Rating: Summarize the overall quality of evidence for each level. Use the “Evidence Level and Quality Guide” 
(Appendix C) to rate the quality of evidence. 
 
Synthesis of Findings: Evidence That Answers the EBP Question 
• Include only findings from evidence of A or B quality. 
• Include only statements that directly answer the EBP question. 
• Summarize findings within each level of evidence. 
• Record article number(s) from individual evidence summary in parentheses next to each statement so it is easy to identify the 
source of the finding.  
 
Develop Recommendations Based on Evidence Synthesis and the Selected Translation Pathway: Review the synthesis of 
findings and determine which of the following four pathways to translation represents the overall strength of the evidence: 
• Strong, compelling evidence, consistent results: solid indication for a practice change. 
• Good and consistent evidence: consider pilot of change or further investigation. 
• Good but conflicting evidence: no indication for practice change; consider further investigation for new evidence or develop a 
research study. 
• Little or no evidence: no indication for practice change; consider further investigation for new evidence or develop a research 
study or discontinue project. 
 
 
 
© The Johns Hopkins Hospital/Johns Hopkins University.  May not be used or reprinted without permission. 
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Appendix F cont. 
Category (Level Type) Total Number of 
Sources/Level 
Overall Quality 
Rating 
Synthesis of Findings  
Evidence That Answers the EBP Question 
Level I 
∙ Experimental study 
∙ Randomized Controlled Trial (RCT) 
∙ Systematic review of RCTs with or without  
  meta-analysis  
 
 
 
2 
 
 
A – High 
quality 
 
TM provides comparable outcomes to FTF (1,2) 
Valid and reliable data collection tools (1,2) 
Evidenced-based care mental health treatment (1,2) 
High risk populations (1,2) 
Level II 
∙ Quasi-experimental studies 
∙ Systematic review of a combination of RCTs and  
  quasi-experimental studies, or quasi-experimental  
  studies only, with or without meta-analysis  
 
 
1 
 
C – Low quality 
Study method (3) 
TM specific satisfaction survey (+ responses) (3) 
Evidenced-based care medications (3) 
TM safety (3) 
High risk populations (3) 
HCP type and mix identified at RS & PS (3) 
Interprofessional collaboration (3) 
Clinical benefit (+ response to treatment) (3) 
Level III 
∙ Non-experimental study 
∙ Systematic review of a combination of RCTs,  
  quasi-experimental, and non-experimental  
  studies, or non-experimental studies only, with or  
  without meta-analysis 
∙ Qualitative study or systematic review of  
  qualitative studies with or without meta-synthesis  
 
 
3 
 
A – High 
quality 
Study method (4,5,6) 
Patient and HCP perspectives (4,5,6) 
Evidenced-based care medications & PC (4,5,6) 
Pregnancy/high risk populations (4,5,6) 
HCP type and mix identified at RS & PS (5) 
Interprofessional collaboration (5) 
TM safety (5) 
Rural – distance & population size (5) 
Author 
         
Morland et al. (2016)  
Morland et al. (2015) 
Nazareth et al. (2013) 
Grindlay et al. (2013) 
Jhaveri et al., (2016) 
Wyatt et al. (2013) 
Hassija & Gray (2011) 
Holyk et al. (2016) 
Hitt et al. (2013) 
Ohl et al. (2013) 
Ross et al. (2016) 
 
Article # 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
 
2 
 
B – Good 
Quality 
Study method (7,8) 
TM specific satisfaction survey (+ responses) (7,8) 
Evidenced-based care (mental health & PC) (7,8) 
TM safety -  safe environment (7,8) 
High risk populations (7,8) 
Response to treatment (↓ symptoms) (7) 
High level of trust with TM (8) 
 
3 
 
C – Low quality 
Study method (9,10,11) 
Clinical benefit (+ response to treatment) (10) 
Evidenced-based care medications & PC (9,10,11) 
Interprofessional collaboration (9,10,11) 
HCP type and mix identified at RS & PS (9,10,11) 
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